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Abstract 
Understanding what molecules are used by neurons and glia for cell-to-cell 
signaling is important as this knowledge provides insights into neuronal network function 
within the brain.  Even after decades of research, novel signaling molecules remain to be 
uncovered in the nervous system.  Since their discovery in the central nervous system, D-
amino acids (D-AAs) have drawn intense research interest because several of them are 
involved in signal transmission processes and brain development.  However, a lack of 
appropriate analytical tools has prevented more refined studies to elucidate the roles of 
D-AAs in intercellular signaling.  Here new and improved analytical platforms are 
described with the aim of sampling the complex neuronal microenvironment, 
accomplishing chiral separations and quantifying low abundant D-AAs reliably.   
Among D-AAs found across the metazoan, two D-AAs are studied extensively, 
namely D-serine (D-Ser) and D-aspartate (D-Asp).  D-Ser can be synthesized 
endogenously by serine racemase which converts L-Ser to D-Ser.  D-Ser can affect the 
activity of N-methyl-D-aspartate (NMDA) receptor, which is an important receptor 
involved in learning and memory formation.  D-Asp levels correlate with embryonic 
development stages and D-Asp concentrations drop to much lower levels in adult animals.  
Through the past ten years of studying D-Asp within Sweedler group, we have 
determined its neuronal localization, biosynthesis, transport, and demonstrated several of 
the physiological responses it elicits within Aplysia californica (A. californica).  
Capillary electrophoresis (CE) is an ideal method to characterize D-AAs in the 
central nervous system due to the compatibility of CE with small size sample and the low 
detection limits it provides when coupled with laser-induced fluorescence (LIF) as a 
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detection method.  Through a variety of CE measurements, two main questions are 
answered in this thesis.  First, is D-Asp released from A. californica neurons and is it 
released in a stimulation-dependent manner?  Second, is D-Ser released from glia via a 
vesicular release pathway?  The first question was answered by selectively extracting and 
quantitatively measuring the extremely diluted D-Asp from the releasates of A. 
californica ganglia.  Our results indicate a stimulation-dependent release of endogenous 
D-Asp, which is the last criterion needed to be satisfied to show that D-Asp meets the 
requirements of a traditional neurotransmitter within A. californica. The second question 
was addressed by quantifying the amino acid contents in intact and leaked glial vesicles.  
Various CE methods were incorporated to validate the quantitation results. These 
analytical measurements clearly show the enrichment of D-Ser, along with another 
signaling molecule L-glutamate (L-Glu), inside glial vesicles.  Together with the results 
of biochemical assays from our collaborator, our data demonstrate D-Ser being stored in 
glial vesicles and released from glia via vesicular release pathway.   
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Chapter 1 
Introduction 
1.1 Research summary 
The research in Sweedler group is conducted at the interface of bioanalytical 
chemistry and neuroscience.  On one hand, we develop analytical platforms enabling new 
measurements that drive scientific advances.  On the other hand, animal model systems 
are carefully chosen to fit the specific questions that we are trying to answer under the 
umbrella of neuroscience.  One of the long-term projects within the group is to elucidate 
unusual neurochemical pathways, and more specifically novel cell-to-cell signaling 
molecules.  A prime example of such an overlooked class of putative signaling molecules 
is the D-amino acids. The lack of appropriate analytical approaches has hindered the 
investigation of the role of chirality in signal transmission.  Previous group members in 
this project had set the background for these experiments [1-5] and created the solid 
foundation on which I started my efforts.  In my research under the guidance of Professor 
Jonathan Sweedler at the University of Illinois, I studied the role that D-Asp and D-Ser 
plays in the central nervous system.  This research, like much of the research in the group, 
required the development of new analytical methods in order to better access these D-
AAs from the brain, and then measure them to answer several critical questions such as 
their presence in vesicles and their release in a chemical-stimulation dependent manner. 
In this chapter, I give background on the foundations of this research.  First, 
neurochemistry is discussed with an emphasis on D-AAs as putative signaling molecules 
in the central nervous system.  Secondly, capillary electrophoresis as the main technique 
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used throughout this research is described, focusing on its usage in neuroscience studies.  
Finally, this chapter ends up with an overview of each chapter in this thesis.  
1.2 Neurochemistry and signaling molecules 
Cells within nervous system communicate in two ways, both chemically and 
electrochemically.  The cell-cell chemical signaling uses chemical compounds released 
from one cell and produces information flow in the following cell(s) by activating 
specific receptors.  Chemical communication is oftentimes categorized as either classical 
neurotransmission (using classical neurotransmitters) and neuromodulation (via 
molecules such as neuropeptides).[6]  Classical neurotransmitters are released by the 
nerve ending of a neuron and cause strong and fast responses in adjacent neurons by 
direct gating of ion channels.  Neuromodulators are not the same.  They can have long-
term effects that are slower to appear; they can trigger responses that involve second 
messengers; they can alter the sensitivity of postsynaptic neurons instead of directly 
acting on them and they are not necessarily released from nerve terminals.[7]  Traditional 
neurotransmitters include small molecules such as L-glutamate (L-Glu), γ-aminobutyric 
acid (GABA), glycine (Gly), and acetylcholine.  In order to define a compound as a 
classical neurotransmitter, it has to satisfy five criteria.[8]  Firstly, the compound is 
present in the presynaptic neuron.  Secondly, it is biosynthesized within that presynaptic 
neuron.  Thirdly, the compound is released under chemical and/or electrical stimulation.  
Fourthly, it causes polarization of the postsynaptic neuron.  Lastly, there is a specific 
reuptake mechanism for its recovery.  It is important to realize that many molecules no 
longer are categorized so neatly, such as nitric oxide, ATP, adenosine.  Regardless, the 
formalism of the classical transmitter still is useful in many cases. 
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Recently, several free D-AAs have been found in the brain and endocrine tissues 
of rats, mice, human beings and many invertebrate nervous tissues.[9]  Among them, D-
serine (D-Ser) and D-aspartate (D-Asp) are the best studied and understood.  The 
biosynthesis of D-Ser is catalyzed by serine racemase, which converts of L-Ser to D-
Ser.[10]  Moreover, studies reveal that D-Ser is a co-agonist of the N-methyl-D-aspartate 
(NMDA) receptor,[11] which is an essential receptor required for long-term memory 
formation.  D-Asp levels correlate with embryonic development stages and its 
concentrations drop to much lower levels in adult animals.[12]  Although several lines of 
evidence suggest that both D-AAs are involved in signal transmission, many questions 
remain, and whether the link is direct or indirect is not well established.     
1.3 Capillary electrophoresis 
The research outlined in the following chapters uses CE as the major approach to 
measure small-volume samples for D-AAs.  What is CE? While a short description is 
given here, several recent reviews provide much greater detail.[13-16]  The simplest 
mode of CE, capillary zone electrophoresis (CZE), separates compounds based on their 
differences of size and charge.  Of course, racemic pairs have the same charge and size to 
each other, so other separation modes are employed such as cyclodextrin modified 
micellar electrokinetic chromatography (CD-MEKC), which is used the most in 
analyzing biological samples.[17]  Differences of amino acid (AA) enantiomers 
partitioning into cyclodextrins (CDs) play an important role in separating them.   
CE has found significant applications in neuroscience.[18-26]  A number of 
features of CE make this approach very suitable for neuroscience investigations.  The 
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small sample requirements of CE, along with the ability to manipulate small volumes, 
allow single cell or even subcellular analyses to be performed on CE.  Of course, a single 
cell does not have much material in it and so detection becomes a challenge.  Luckily, CE 
can be coupled with a number of detection methods, such as laser-induced fluorescence 
(LIF), which then creates a system with excellent mass detection limits for a wide range 
of signaling molecules. When mass spectrometry (MS) is coupled with CE, separated 
compounds can be identified with confidence and information of unknown peaks can be 
obtained.  A detailed discussion on measuring endogenous D-AAs using CE is presented 
in section 2.2.1 in chapter 2. 
1.4 Overview of thesis 
The content of subsequent chapters in the dissertation is summarized below.  
Chapter 2 reviews the techniques and highlights the field of measuring endogenous D-
AAs in the brain, which were reported from 2005 to 2011.  Although the main focus is on 
the brain, other studies that investigate functional roles of D-AAs in invertebrate nervous 
system are included. Measurements conducted using cell cultures with significance in 
neuroscience are also included.  Significant effort is made to highlight: (1) newly 
developed or newly implemented approaches and (2) measurement results that lead to a 
better understanding of the functional roles of D-AAs.  
Chapter 3 presents research to determine whether D-Asp is released in a 
stimulation-dependent manner in Aplysia californica (A. californica). This was critical 
information missing from our prior studies and is needed in order to understand if D-Asp 
can be a neurotransmitter.  We employ two different sample collection and sample 
5 
 
preparation methods.  One is by directly collecting extracellular environment.  We 
developed a protocol using liquid-liquid extraction method to specifically extract amino 
acids out while leave salt behind.  Another uses solid phase extraction (SPE) –based bead 
sampling technology as used in previous peptide studies by our group,[27] which allows 
more defined analyses in terms of spatial information on the release locations. Our 
findings show that D-Asp is released from neurons in a stimulation-dependent manner. 
With our prior work, we now have demonstrated that D-Asp fulfills all criteria of 
neurotransmission within the A. californica central nervous system. 
Chapter 4 describes a fundamental study on D-Ser, representing a large 
international collaboration project. The goals of this work were to show the storage and 
uptake of D-Ser into astroglial vesicles.  Whether D-Ser is released from glia via 
vesicular pathway is a controversial topic within D-Ser community.  Here we address the 
question by quantifying the amino acid contents in immunoisolated glial vesicles, both 
leaked and intact.  Our analysis shows the existence of a population of GVs which stores 
D-Ser and L-Glu, with estimated intravesicular concentrations of ~20 mM.  This level is 
within the acceptable range of the concentration of other signaling molecules. Because 
this collaboration is meant to address this question in a definitive manner, we verified the 
quantitation results using three different CE methods, on two CE platforms, CE-LIF and 
CE-MS.  When our analysis results are combined with the imaging, molecular, 
physiological and biochemical data from our collaborators, we conclude that vesicles in 
astroglia do exist, and they store and release D-serine, L-glutamate, and most likely other 
neuro- and gliamodulators. 
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Chapter 5 is more preliminary in nature and describes several ongoing method 
development projects on CE-LIF aiming to provide sensitive, reliable measurement of D-
glutamate, D-alanine and D-proline.  They D-AAs are poorly studied and little is known 
about their functions except that they occur in the central nervous and endocrine 
systems.[28-32]  Although most analytical measurements of these three D-AAs employed 
high-performance liquid chromatography (HPLC), my goal was to adapt CE, useful 
because of the reasons given above (e.g., the ability to analyze d-AAs in single cells.) 
The newly developed analytical methods, in combination with appropriately designed 
experiments, will help to uncover the roles of these D-AAs play in cell to cell signaling in 
nervous and endocrine system. 
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Chapter 2 
Measuring Endogenous D-Amino Acids in Brains 
2.1  Introduction 
Chirality is a common feature in most compounds found in nature.  The 
physiological environment within a living system is chiral and the biological activities of 
molecules of different chirality differ dramatically.[1]  Among the twenty essential amino 
acids which commonly occur in all organisms, only glycine lacks a chiral center.  It was 
long believed that only L-amino acids (L-AAs) exist in higher animals and their D 
counterparts, are present solely in lower species like microorganisms and bacteria.   
The first report of significant endogenous D-amino acids (D-AAs) in the animal 
kingdom was free D-alanine (D-Ala) from the blood of the milkweed bug isolated by 
paper chromatography and detected using D-amino acid oxidase-linked (DAAO-linked) 
colorimetric assay.  This was followed by finding of several D-AAs in mammals, such as 
D-aspartate (D-Asp) in humans,[2, 3] neonatal rat brain,[4] as well as D-serine (D-Ser) in 
human and rat brain.[3]  Hundreds of studies now document the widespread occurrence 
of D-AAs across the Metazoan.  
The presence of D-AAs in the brain or central nervous system (CNS) has implied 
their importance and further studies have confirmed their roles. For example, D-Ser 
accumulates in astrocytes located nearby neurons with a high expression of N-methyl-D-
aspartate (NMDA) receptor,[5] which is an important player in  learning and memory 
formation.  Intriguingly, D-Ser binds to the glycine binding site of the NMDA receptor 
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while potentiates its activity.[6]  D-Asp is the second most studied endogenous D-AA in 
animals.  So far, it has been found in all examined animals.  Interestingly, D-Asp levels 
are relatively high during embryonic development, but its concentration decreases 
substantially in adult animals.[3]  These D-AA studies describe specific biological 
functions, with D-Ser playing an important role in neurotransmission and D-Asp in 
development.  Moreover, altered levels of D-AA are related to the developmental stages 
of many nervous system diseases, such as Alzheimer’s disease (AD) and Parkinson’s 
disease (PD), although their involvements in these processes have yet to be confirmed.[7] 
Endogenous D-AAs in animal CNS have been characterized using a variety of 
separation and measurement techniques.  Techniques can be categorized into separation 
based and non-separation based.  Separation based approaches comprise of capillary 
electrophoresis (CE), high performance liquid chromatography (HPLC) and gas 
chromatography (GC).  These approaches can be coupled with different detection 
methods such as laser-induced fluorescence (LIF), mass spectrometry (MS) or ultraviolet 
(UV).  These instrumental platforms usually provide high separation efficiency, good 
sensitivity as well as great repeatability and allow high-throughput measurements of D-
AAs along with other analytes of interest in one single run.[8]  On the other hand, non-
separation based techniques, including immunostaining and enzyme-linked assays, could 
have advantages over separation based approaches, especially when specific analytes are 
being assayed.  For example, immunostaining provides a straightforward image that 
relates analytes with morphological structures and enzyme-linked assays can deliver 
close to real-time responses, although both require pre-selected D-AAs.   
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This review primarily focuses on the measurements of endogenous D-AAs in the 
brain using the techniques stated above that were reported from 2005 to 2011.  The main 
focus is on the brain, including mammals and invertebrate nervous system. 
Measurements conducted using cell cultures with significance in neuroscience are also 
included.  We balance our discussion between techniques themselves and the scientific 
significance of those measurements.  Measurements in clinical research and disease 
diagnosis are discussed separately.  Significant effort is made to highlight: (1) newly 
developed or newly implemented approaches and (2) measurement results that lead to a 
better understanding of the functional roles of D-AAs.  
2.2 Separation based techniques 
2.2.1 CE 
2.2.1.1 Techniques 
 2.2.1.1.1 Separation 
Cyclodextrin-mediated enantioseparation is the most widely used separation 
technique used in measuring D-AAs in biological matrix using CE.[9]  It can be 
categorized into three different modes: CD-capillary zone electrophoresis (CD-CZE), in 
which neutral CDs are added into background electrolyte (BGE); CD-electrokinetic 
chromatography (CD-EKC), in which charged CDs are added; CD-micellar electrokinetic 
chromatography, in which surfactants and CDs are both added.  The mechanism of these 
modes has been discussed in detail in a recent review.[10]  A variety of CDs (native CDs 
and CD derivatives) and several surfactant (chiral and achiral) have been employed in 
bioanalytical CE approaches, which have been recently reviewed.[9, 11-14]  Besides the 
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types and concentrations of CDs and surfactants, the chiral separation efficiency can also 
be affected by pH, BGE and other additives, such as saccharides [15] and organic 
modifier.[11]  It is important to note that chromatographic mechanism plays a more 
significant role by distributing chiral amino acid at different extents between bulk 
solution and chiral selectors.[16]  
One of the most attractive advantages of EKC is that one can alter the separation 
efficiency towards various analytes by changing the types and concentrations of 
components in the separation buffer, without modifying a traditional CE system.  
Moreover, it is cost-effective because usually low concentration of chiral selectors and 
small volume of media are required in the buffer condition.[17]  
2.2.1.1.2 Detection 
Besides the separation, it is important to be able to detect the analytes.  Laser-
induced fluorescence (LIF) allows  the measurement of  low abundant endogenous D-
AAs as it provides the lowest reported limit of detection among detection methods 
coupled with CE.[18]  CE-LIF instruments use a laser to excite the fluorescent analytes, 
and the resulting fluorescence emission is focused by optics and subsequently 
detected.[19]  The ability to use CE-LIF for detecting D-AAs in single cell and 
subcellular regions has facilitated our understanding of D-AAs as signaling molecules.  
In addition, LIF is the most common detection system coupled with microdialysis either 
on-line or off-line.[18]  
Light-emitting diode-induced fluorescence (LEDIF), used less often, is an 
alternative to lasers as a source for fluorescence detection with lower cost and usually, 
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with poorer detection limits.  However, it can provide limits of detection (LOD) that 
allow measurements of D-AAs in biological matrices.  Li et al. described within-column 
LEDIF detection with a LOD at 2.6 x 10
-8
 M for D-Ser.  To avoid the possible light loss 
from light-emitting diode (LED)’s limited power, the upper end of optical fiber was 
inserted parallel into the separation capillary with excitation light transmitted directly to 
reach the detection window.   
Radionuclide detection coupled with CE is an excellent choice for studies on 
conversions from L-AA to D-AA, such as D-AA biosynthesis, transport and reuptake 
process.[20]  Those investigations can be facilitated by carefully designed experiments 
using radiolabeled precursors of D-AAs.  Newly synthesized D-AAs can be differentiated 
from both the precursor (i.e. radiolabeled L-AAs) via CE separation and the endogenous 
pool via radionuclide detection.  As a result, the percentage of newly synthesized D-AAs 
can be measured and calculated.   
2.2.1.1.3 Sampling  
Bulk tissues and body fluids are still the most common type of samples being 
analyzed by CE.  With tissue punches and slices, a degree of spatial resolution and 
relatively consistent sample size can be obtained.  D-AAs have been measured in a 
variety of brain samples, such as, A.californica ganglia,[15, 21, 22] artic ground squirrel 
brain tissue,[23] rat brain tissues [15, 24] and human CSF.[25] 
Sampling smaller tissue such as single cells can often provide valuable 
information because of the heterogeneity in chemical composition and function of 
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individual or even adjacent neurons.[26]  These measurements are made feasible because 
of the compatibility of CE with small sized sample and its high sensitivity. 
Besides dissection, microdialysis has become a useful tool to retrieve information 
from brains in vivo.  The small volumes of CE work well with the small sampling probes 
used in microdialysis. Temporal resolution is an important consideration and is often 
limited by both derivatization reaction time and separation time.[27]  Various approaches 
have been developed to improve on this point by either exquisitely designing the 
microdialysis-CE interface [28] or collecting samples off-line at short intervals.[29]  For 
example, O’Brien et al. established a high-throughput on-line microdialysis-capillary 
electrophoresis (MD-CE) system [28] using a customized flow-gated injection interface 
(Figure 2.3a) which switched between injection and separation. This MD-CE system 
greatly improved sample throughput by eliminating several manual steps including 
sample pretreatment, derivatization and by shortening the migration time of D-Ser to only 
22s.  An alternative way to improve temporal resolution is by collecting samples off-line 
at short intervals.  Kirschner et al. designed a new brain slice microperfusion device 
coupled offline to CE-LIF with a 2 min temporal resolution by manually collected 
dropwise off-line every 2 min and separated by a CE-LIF system.[29] 
2.2.1.2 Applications 
The suitability of CE for the determination of D-AAs in biological matrix has 
encouraged its use in various studies, most aiming to elucidate the functional roles of D-
AAs in the CNS.  There are a number of references that detail the CE methods used to 
measure endogenous D-AAs.[17, 30]  In the past 6 years, CE measurements have further 
documented the occurrence of D-AAs in the brains of many animals.  These include D-
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Asp in A. californica CNS,[21, 22, 31, 32] human CSF,[33, 34] rat brain;[34, 35] D-Ser 
in rat brain,[24, 29, 36] mouse brain,[37] A. californica CNS;[38] D-Glu in rat brain.[34]  
Moreover, a number of insightful results have been obtained towards understanding the 
roles of these D-AAs in the CNS. 
Single cell and subcellular analysis has proven to be fruitful in studying 
heterogeneity of D-AA levels not only from cell to cell, but also from different 
subcellular domains of a cell.  For example, our group found that the percentage of the 
Asp in the D-form considerably varied in different identified neurons of A. californica.  
The ratio of D-/L-Asp was reproducible in the same regions (cell clusters or single cells) 
and varied region to region with small variance from animal to animal (Figure 2.1).[32]  
In addition, the analysis of subcellular domains revealed the presence of D-Asp in both 
cell soma and cell processes, suggesting it undergoes transport to distant release sites.[31]   
With the question that whether D-Asp acts as a traditional neurotransmitter in 
mind, various CE-LIF measurements were performed in A. californica to further 
investigate the mechanisms including synthesis, transport, and secretion of this putative 
signaling molecule.  A pharmacological study suggested both D-Asp and L-Asp were 
transported in a major nerve in a colchicine-dependent manner, where colchicine can 
serve as a vesicle transport blocker.  These results pointed to an active transport of D-Asp 
via vesicles in A. californica.[31]  In a more recent study, we detected the activity-
dependent release of endogenous D-/L-Asp from ganglia of A. californica upon KCl and 
calcium ionophore stimulation.  When calcium ionophore was used as stimuli, the release 
of D-Asp was even much more pronounced compare to that of L-Asp.  These results 
support the concept of Ca
2+
-dependent D-Asp release from neurons, in line with vesicular 
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release mechanism.[21]  A CE-LIF system assembled with off-line fraction collection [20] 
and radionuclide detection has been implemented by our group to examine the 
biosynthesis of D-Asp from L-Asp in A. californica. (Figure 2.2)  An average of 36% 
[
14
C]D-Asp radioactive signal provided clear evidence of active synthesis of D-Asp from 
L-Asp in the A. californica CNS.[32]  All these data support the fact that D-Asp satisfies 
the criteria of a traditional neurotransmitter within A. californica.  
The dynamic nature of D/L-Asp was investigated by S.L. Zhao et al. by 
quantitatively measuring them in rat brains at different development stages.  D-Asp levels 
appeared to decrease rapidly after birth while L-Asp acted oppositely.[35]  This 
corresponds to the pioneer work of D-Asp analysis by Hashimoto using HPLC,[3] and 
can be advantageous over HPLC when dealing with small volume samples, such as single 
cells.   
Some insights as to the neuromodulator action of D-Ser as well as its fluctuation 
in nervous system development were also provided by CE measurements.  With a CE-
LEDIF method, Li et al. measured D-Ser contents in the midbrain of  mice induced with 
PD symptoms, showing first increase then steep drop of D-Ser level.  The results 
suggested that the biosynthesis and the transportation of D-Ser might be involved in PD 
pathogenesis.[24]  By analyzing the off-line collected samples from push-pull perfusion, 
Kirschner et al. found that D-Ser and L-Glu efflux from acute slices had similar timing of 
release.  This is critical considering that both agonists are required for NMDA receptor 
excitotoxicity.[29]  In a set of pharmacological-assisted measurements using MD-CE, it 
was suggested that extracellular concentration of D-Ser was regulated by the involvement 
of Ala-Ser-Cys neutral amino acid transporters.[39]  The advances of MD-CE technique 
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also helped to demonstrate that the release of D-Ser upon depolarization was a 
physiological pathway in vivo.[36]  Due to the improved temporal resolution (1.25 min) 
compared to traditional microdialysis (20 min), Rosenberg et al. were able to observe the 
significant increase in extracellular D-Ser concentration elicited by (Figure 2.3b) 
veratridine,[36] which was not observed previously.[40]  This is an excellent example 
demonstrating the benefit of faster MD-CE. 
2.2.2 HPLC 
2.2.2.1 Technique 
In chromatographic separations, chiral separations can be categorized as indirect 
or direct.  In indirect approach, the resolution of enantiomers is achieved by forming 
diastereomers with chiral reagent, followed by their separation using achiral 
chromatographic modalities.  The indirect approaches [41, 42] developed decades ago are 
still used in analyzing D-AAs in biological matrix nowadays.  Direct approach requires 
no chemical derivatization with chiral reagent prior to separation, but involves using 
chiral selectors either in mobile phase or on stationary phase known as chiral stationary 
phase (CSP).  There have been several newly developed direct approaches reported in the 
past six years.[43, 44]  Although not required in direct approaches, derivatization usually 
is to be performed to attach a fluorescent moiety onto D-AAs to assure good 
detection.[16]   
2.2.2.1.1 Methods based on indirect separation mechanisms 
Several derivatizing systems were developed to form diastereomers with D-AAs 
and enabled enantioseparation of D-AAs in biological samples on common C18 columns. 
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The chiral derivatizing agents used in HPLC separation of AA enantiomers have been 
recently reviewed.[45]  One of the first methods identifying endogenous D-AAs was 
developed by Hashimoto et al. almost two decades ago,[42] and is still widely used for 
the analysis of endogenous D-Ser, D-Asp and D-Ala.[46-48]  Chiral resolution is 
achieved by derivatization using OPA and a chiral thiol N-tert-butyloxy-carbonyl-L-
cysteine (BOC-L-cys) in combination with gradient elution.  Another indirect HPLC 
method being successfully implemented in analyzing D/L-Asp in biological matrix is an 
OPA and N-acetyl-L-cysteine (NAC) derivatization system introduced by Aswad.[41]   
Marfey’s reagent, 1-fluoro-2,4-dinitrophenyl-5-L-alanine amide, is also widely 
used in the analysis of chiral amino acids.  The resulting derivatives of amino acids can 
be detected by both, simple UV as well as more selective mass spectrometry.[49-51]  A 
rapid and sensitive gradient elution liquid chromatography-electrospray ionization-
tandem mass spectrometry (LC-ESI-/MS/MS) approach was developed recently utilizing 
C-18 column for separation and a Q-trap in negative ion mode for detection. Quantitation 
was carried out by MS/MS in selective reaction monitoring (SRM) mode.[50]  
2.2.2.1.2 Methods based on direct separation modes  
  Besides forming diastereomers followed by non-chiral columns, methods have 
also been reported utilizing achiral fluorescent derivatizing reagents in conjunction with 
chiral HPLC columns to separate AA enantiomers.  For example, the achiral NBD-F 
labeling reagent offers superior stability compared to OPA while requires elevated 
reaction temperature and longer reaction time.[52]  The increased hydrophobicity after 
NBD-F derivatization also facilitates sample pre-concentration.  Song et al. reported a 
novel sensitive chiral capillary high performance liquid chromatography-tandem mass 
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spectrometry (HPLC-MS/MS) method.  This system employed a C18 column to pre-
concentrate samples and a chiral column packed with teicoplanin aglycon to separate 
NBD-F tagged amino acid enantiomers.  The detection using tandem MS with SRM led 
to excellent sensitivity and selectivity.  Thanks to this high selectivity, a stable isotope–
labeled analyte analogue (i.e., L-Asp-2,3,3,-d3) could be introduced as an internal 
standard to improve the reproducibility and reliability of quantitative analyses.[43, 44]   
Many separations of NBD-F tagged racemic AAs have been performed on a very 
neat automate column-switching 2D-HPLC system (Figure 2.4a).  This technique 
particularly allows highly sensitive and selective analysis of AA enantiomers in 
complicated biological system because in the first dimension, the racemic mixtures can 
be preselected from complicated biological matrix on a reversed-phase column.  The first 
stage separation greatly reduced the complexity of fractions to be separated on the second 
stage by a chiral column.[53]  This system had an limit of detection (LOD) of 500 
amol/injection for NBD-D-Ser and NBD-D-Ala as well as a total 30 min separation time, 
which were both advantageous over the similar system reported earlier.[54]  In addition, 
the quantitation values of AA enantiomers could also be confirmed using an opposite 
enantioselective column with reversed elution order, which greatly increased the 
reliability of the results.  Separation of AA pairs could be achieved by optimizing 
parameters of individualize protocols, including mobile phase composition, column, etc.  
High cost is a major limitation of this system owing to the two fluorescent detectors and 
multiple LC columns.[52]  
2.2.2.2 Applications 
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In the past 6 years, various LC methods have been used to further characterized 
D-AAs in different biological matrix, including neuronal culture,[46] subcellular 
organelles of Aplysia limacine (A. limacine),[55] A. californica CNS,[43, 44] rat brain 
tissues,[44, 48, 56-60] mouse brain tissues,[53, 61] microdialysates from rat brain,[47, 50] 
and human CSF.[51] 
LC measurements have provided many insightful results increasing our 
understanding of the biosynthesis of D-Ser in the brain.  The synthesis of neuronal D-Ser 
was demonstrated in neuronal cultures containing minimal amounts of glia.  Interestingly, 
in pure neuronal culture, synthesis of D-Ser in neurons required the uptake of 
extracellular L-Ser,[46] which may be supplied by glial cells under normal conditions.[62]  
Yang et al. performed a 2D-HPLC analysis to elucidate the role of brain L-Ser synthesis 
in modulating D-Ser level by measuring their concentration in the brain of conditional 
Phgdh mutant mice.  Phgdh catalyzes the first step in L-Ser synthesis.  A markedly 
decrease of D/L-Ser in the cerebral cortex and hippocampus of knock-out mice provided 
proof that endogenous L-Ser synthesis via phosphorylated pathway can play a pivotal 
role in controlling the level of endogenous D-Ser.[61]   
Moreover, several proteins possibly regulating SR have been investigated on their 
effects on D-Ser synthesis, including protein interacting with C-kinase 1 (PICK1), 
aminooxyacetic acid (AOAC). Levels of D-Ser were decreased in the forebrains of 
neonatal mice with PICK1 knockout, indicating the regulation of brain D-Ser levels by 
PICK1 in a spatially and temporally specific manner.[63]  Protein kinase C (PKC) 
activation reduced D-Ser levels in vitro while its inhibition increased cellular D-Ser level.  
Manipulating PKC activity in vivo also regulated D-Ser level in rat frontal cortex.[48]  
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AOAC acts as an inhibitor of pyridoxal phosphate-dependent enzymes, which SR 
belongs to.  The perfusion of AOAC can induce a significant decline in the extracellular 
concentration of D-Ser in the striatum.[64] 
DAAO has been long known to have D-Ser degradation activity.[65]  Endogenous 
D-Ser and D-Ala in the tissues and physiological fluids of mice with various DAAO 
activities were measured with a 2D-HPLC method.  The amounts of both DAAs 
increased drastically with a lowered DAAO activity except for the cases of D-Ser in the 
frontal brain regions (Figure 2.4b and 2.4c).[53]  Besides DAAO, SR has been proposed 
to be another moiety regulating endogenous D-Ser levels through an α,β-elimination 
activity, especially in brain areas where DAAO is not present.  This was supported by the 
results that levels of D-Ser synthesized with impaired α,β-elimination activity were 
several-fold higher than wildtype both in vitro and in vivo.[66] 
In addition and biosynthesis and degradation, new measurements of endogenous 
release have also been accomplished by LC.  Kanematsu et al. observed a reduced 
cortical extracellular content of D-Ser during the intra-cortical infusion of a glia toxin.  
These findings suggested that glial cells participated in controlling extracellular D-Ser 
contents in the rat medial prefrontal cortex.[47]  Kakegawa measured D-Ser secreted 
from glia in rat cerebellar slices and showed that endogenous D-Ser was released mainly 
from Bergmann glia by parallel fiber burst stimulation in immature, but not mature 
cerebellar slices.[58]  Spinelli et al. detected high levels of D-Asp in isolated 
synaptosomes and synaptic vesicles in Aplysia limacine.  Moreover, D-Asp release was 
observed from synaptosomes by both K
+
 and ionomycin stimulation, indicating a possible 
role for D-Asp in neurotransmission.[55]  
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Topo et al. investigated the role of D-Asp in learning and memory processes of 
the rat.  They found a good and significant correlation between endogenous D-Asp 
concentration in rat hippocampus and the amount of time to complete a task, indicating 
the involvement of D-Asp in learning and memory formation.[56]  The 2D-HPLC 
measurements of D-Ala in rats demonstrated an intriguing circadian rhythm of this 
molecule.  Its amount in rat plasma, pancreas and anterior pituitary gland was high during 
the sleeping period and low during the active period in rats with both diurnal and 
nocturnal habits.  Interestingly, L-Ala and other D-amino acids including D-Asp and D-
Ser didn’t show an obvious circadian rhythm.[57]        
2.2.3 GC 
While gas chromatography is a fast and efficient way to separate amino acid 
enantiomers in bulk tissue, it is less used in measuring endogenous amino acid 
enantiomers in small biological samples due to the difficulty in sample preparation.[52]  
Among the GC methods for chiral amino acids separation, one of the most successful 
approaches to analyze biological samples is achiral derivatization with 
pentafluoropropionic anhydride (PFPA) followed by chiral separation on a Chirasil L-
valine column.[67]  Chirasil L-valine column is a chiral column in which the stationary 
phase of L-Val was coupled to a fused silica glass.  Separation is dependent on formation 
of multiple hydrogen bonds of analytes with the stationary phase.[68]  This GC approach 
coupled with mass spectrometry in the selective ion detection mode was described to 
quantify D-AAs in the brains of a wide range of higher vertebrates.  D-Ser has been 
detected in almost all surveyed animals except birds, indicating the ubiquity of D-Ser in 
vertebrate brains.[69] 
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2.2.4 Enzymatic methods to verify D-AA identity in separation results 
In the complex biological system, a clean discrimination of chiral enantiomers 
cannot always be easily achieved even when standards can be well resolved.  This is 
more common when the differences in concentrations between the D-AA and the L-AA 
are great and D-AAs only exist at trace level, or when small changes of D-AAs needs to 
be detected.  Several approaches have been developed to overcome these challenges.  If 
the expected D-AA is masked by a known peak, specific enzyme can be applied to 
remove the masking peak. For instance, Rosenberg et al. employed glutaminase to 
remove glutamine, which masked the small D-Ser peak in their HPLC analysis.  It greatly 
improved the chromatographic separation of D-Ser and allowed endogenous D-Ser 
release from cultured neurons to be measured.[36]  Even when there is no known peak 
co-migrating with the targeted D-AA peak, more than one technique or addition 
confirmation using enzyme reaction is preferred to validate the identity of D-AA peak in 
complicated biological matrix.  DAA peak can be selectively removed by enzyme and 
antibody incubation, including DAAO, D-Ser deaminase,[70] d-aspartic acid oxidase (D-
ASPO) [55, 56, 71] and D-Asp antibody.[72]   
2.3 Non-separation based techniques 
2.3.1 Enzyme-linked assays 
Although analytical separation methods discussed above offer highly sensitive, 
greatly selective and very quantitative measurements of endogenous D-AAs, they are 
typically not suitable for on-line analysis except when coupled on-line with microdialysis.  
Even microdialysis sampling could be limited by their large sized probes as well as the 
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slow diffusion of molecules through the dialysis membrane.  In addition, purchasing, 
building and maintaining a complicated analytical instrument can be a huge investment.  
An alternative way is to use enzyme-based techniques, which offer simplicity of design, 
high sensitivity and more importantly the potential to quantify D-AA variations in vivo in 
real time. 
2.3.1.1 Microsensor 
Pernot et al. have developed a microbiosensor by covering a cylindrical platinum 
microelectrode with a membrane of poly-m-phenylenediamine (PPD) and a layer of 
immobilized D-amino acid oxidase from the yeast Rhodotorula gracilis (Figure 2.5).[73] 
The diameter of the tip was about 25 µm.  This sensor functioned by detecting the 
hydrogen peroxide produced from enzymatic degradation of D-Ser and had an in vivo 
detection limit of 16 nM.  Rhodotorula gracilis D-amino acid oxidase (RgDAAO) 
provided a more active and more selective detection over the previously used porcine 
kidney D-amino acid oxidase (pkDAAO).  In addition, the used of a highly selective PPD 
layer blocked 97% of the nonspecific oxidation of endogenous oxidizable molecules.  
Although several D-amino acids could be potential substrates for RgDAAO, D-Ser was 
the only endogenous substrate sufficient to be detected by the sensor in the central 
nervous system.  This device has been tested on measuring D-Ser in rat cortex after an 
intraperitoneal injection.[73] 
2.3.1.2 Chemiluminescent detection 
Besides detecting the resulting H2O2 oxidation current induced by DAAO enzyme 
reaction, chemiluminescent provides an alternative detection option. This detection, 
although can also provide real-time responses with simplicity, does not offer as good 
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spatial resolution as microbiosensor, because the detection is usually performed in a 
solution instead of a single spot.  The mechanism is based on measuring the light of a 
luminescent compound produced by the reaction of hydrogen peroxide with peroxidase 
and luminol.[74]  Assays using this method have been performed to measure D-Ser 
during vestibular nuclei (VN) postnatal development, showing a strong variation 
depending on the postnatal developmental stages. The level of D-Ser peaked at one week 
and dropped gradually afterwards.[75]  Mothet et al. applied this enzyme-linked method 
to monitor D-Ser release from cultured astrocytes in a neuropharmacological study, 
aiming to learn the mechanism of D-Ser release from glia.  One of the most intriguing 
observation was that receptor-mediated D-Ser release was calcium-dependent, a feature 
shared by other gliotransmitters such as glutamate and ATP (Figure 2.6).  They also 
demonstrated that agonist-evoked release of D-Ser was sensitive to tetanus neurotoxin, 
which proteolyzed soluble NSF attachment protein receptors (SNAREs) on the vesicle 
membranes.  Their data together supported Ca
2+
-dependent vesicular release of D-Ser 
from glial cells.[76]  The same chemiluminescent assay was applied to determine the D-
Ser content in hippocampus, revealing its amount in young rats decreased to only about 
1/6 in aged rats.[77]   
2.3.1.3 Colorimetric detection 
D-AAs can also be determined by colorimetrically measuring the α-ketoacids 
produced by oxidation of D-AAs with DAspO or by DAAO.  Spinelli et al. have used 
DAspO to measure the sum of D-Asp+NMDA+D-Glu and DAAO to measure the total 
other DAAs in the nervous tissues of A. limacina.[55]    
2.3.2 Immunostaining 
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Immunostaining is an excellent method to locate D-AAs of interest in brain 
tissues.  Antibodies have been raised specifically to the targeted analytes including D-
Ser,[46, 75, 78-81] D-Asp,[82] D-Ala,[83, 84] and D-Glu.[85]  Cross-reactivity is a 
challenge that needs to be addressed before immunostaining is performed on biological 
samples.  Specificity of antibodies can be tested using dot-blotting or western blotting to 
make sure the purified antibodies do not or negligibly conjugate with molecules other 
than targeted analytes.  In addition, standard control experiments need to be performed 
including the use of pre-immune sera, pre-absorption of diluted antibodies with the target 
peptide or amino acid that they are raised against.[86] 
2.3.2.1 D-Ser 
D-Ser has been intensively studied by immunostaining to determine its 
distribution in tissues and subcellular localization inside both neurons and glia. One of 
the controversial topics in D-Ser community is the distribution of D-Ser.  Is D-Ser is 
localized exclusively in neurons or glia, or both?  Is this distribution changes along with 
development?  Numerous immunostaining studies have unveiled the answers.    
Immunostaining has been performed extensively to investigate the localization of D-Ser 
in both brain tissues and cell cultures. Previous research has demonstrated that D-Ser was 
found mainly in astrocytes, but not neurons.  Kartvelishvily et al. improved the staining 
by employing a different antibody raised against D-Ser-glutaraldehyde conjugate and 
incubating thinner sections for longer time.  These advances enhanced immunoreactivity 
and resulted in lower background staining, which was crucial for the observation of 
neuronal staining.  They also quenched glutaraldehyde autofluorescence.  All these 
improvements enabled a clear staining for D-Ser in neuronal cell bodies and processes in 
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all layers of the cerebral cortices of rats.  However, in other brain areas, glial staining was 
predominant (Figure 2.7).[46]  Another interesting study stained D-Ser in rat retina to 
investigate the developmental change of D-Ser concentration level in neuronal ganglion 
cells of the retina.  Sections were fixed for 10 min in 4% p-formaldehyde prepared in 
phosphate-buffer saline (PBS).  The level of D-Ser was quite high in ganglion cells of 
neonatal retinas while decreased rapidly postnatally.[81]  Glutaraldehyde-fixation can 
result in the difficulty of co-localization of D-Ser antibody with glutaraldehyde-fixation-
sensitive antigens.  To overcome this challenge, Williams et al. raised a new D-Ser 
antibody optimized for formaldehyde-fixation instead of glutaraldehyde fixation.  With 
this method, they were able to characterize novel anatomical compartmentalization of D-
Ser in glia.  Instead of uniformly distributed in cytoplasm, D-Ser was found to be 
enriched into vesicle-like compartments in astrocytes and radial glial cells.  Moreover, in 
aged animals, immunolabeling for D-Ser was absent in patches of cortex and 
hippocampus, suggesting an impaired glial modulation of forebrain glutamatergic 
signaling might occur.[78]    
Double-staining can deliver a more comprehensive and more convincing results 
about cellular distribution of D-AAs by supplying information of the co-localization of 
two targets.  More importantly, by staining subcellular organelles and D-AAs 
simultaneously, double-staining can implicate the subcellular localization of D-AAs.  
Magalie et al. performed an elegant study to address the question whether D-Ser was 
distributed in vesicles of the regulated secretory pathway using cultured cortical 
astrocytes.  eGFP-synaptobrevin/VAMP2 (eGFP-Sb2) and eGFP-cellubrevin/VAMP3 
(eGFP-Cb) were used to mark synaptic-like vesicles and their co-localizations with D-Ser 
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were quantified.  Their results indicated that near one-fourth of D-Ser is present in partial 
but not all vesicles of the regulated secretory pathway (Figure 2.8).[87]  A single and 
double immunolabelings also revealed high concentration of D-Ser and its biosynthetic 
enzyme, serine racemase, in the supraoptic nuclei (SON).  By double immunolabeling, it 
was demonstrated that both were localized in all SON astrocytes but D-Ser was not 
observed from neuronal elements.[79]  In neurons, D-Ser was revealed in a subset of 
glutamatergic neurons with dual immunofluorescence labeling for glutamate and D-
Ser.[78]  Puyal et al. double-immunolabeled D-Ser with neurons and glial cells 
respectively in VN sections of rat brains.  Β2-Tubulin was used to label neurons while 
GLAST, GFAP and S100β to verify D-Ser in glial cells.  Interestingly enough, the 
cellular localization was found to be associated with postnatal development stages.  For 
example, during the first three weeks, it was mainly localized in glial but switched from 
glia to neurons afterwards, indicating that D-Ser may have distinct functional roles 
depending on the maturation stage of the vestibular networks.[75]  In neurons, D-Ser was 
revealed in a subset of glutamatergic neurons with dual immunofluorescence labeling for 
glutamate and D-Ser.[78]   
2.3.2.2 D-Asp 
As D-AAs like D-Asp are usually thought to be synthesized endogenously, their 
co-localization with various enzymes has been well studied.  Immunohistochemistry 
revealed that D-Asp and D-Asp racemase (DR) have similar localizations in the rat brain 
including paraventricular nuclei (PVN) and supraoptic nuclei (SON) as well as other 
tissues, indicating that DR plays an important role to generate endogenous D-Asp.[82]  
2.3.2.3 D-Ala 
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Using mouse monoclonal antibody against D-Ala,[83] Etoh et al. visualized the 
cellular localization of D-Ala for the first time in the rat pituitary gland, which is the 
tissue containing the highest amount of D-Ala in the rat brain.  In particular, they double 
stained D-Ala with five types of cells secreting specific hormones to identify the type of 
D-Ala immunopositive cells.  The double-immunostaining results display a similar 
distribution of D-Ala with adrenocorticotropic hormone (ACTH) cells.  Along with their 
previous results of D-Ala co-localization with insulin-secreting beta-cells in rat pancreas 
[83], the data shows an intriguing colocalization between important hormones, ACTH 
and insulin, that regulate blood glucose levels, and D-Asp.[84]   More research is needed 
to resolve these questions. 
2.3.2.4 D-Glu 
Given the importance of L-Glu transmission in the brain of all animals studied, it 
is surprising how little data exists on D-Glu.  Mangas et al. showed a clear visualization 
of a sparse localization of D-Glu-immunoreactive cell bodies for the first time in the rat 
brain by taking advantage of the high affinity and specificity of the antiserum directed 
against conjugated D-Glu. The immunoreactivity of D-Glu was only observed in 
mesencephalon and in the thalamus and confined to neuronal structures.[85]   
2.4 Clinical and pharmaceutical applications 
D-AAs have drawn intense interest from pharmaceutical industry because of their 
possible correlation with several mental diseases, such as Alzheimer’s disease (AD) and 
Parkinson’s disease (PD).  Measurements have been performed on samples obtained from 
diseased vertebrate animal models or even human beings.  Given its excellent 
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quantitation ability, high reproducibility and automation, HPLC methods are used almost 
exclusively in clinical studies. 
The method of reversed-phase HPLC following Boc-L-Cys-OPA 
derivatization,[42] was employed to investigate the difference of D-Ser level in 
schizophrenia patients vs. healthy control subjects.  A significant 25% decrease in CSF 
D-Ser levels suggests D-Ser disposition maybe altered in the disease.[70]  Yoshikawa et 
al. applied the same method to monitor D-Ser level after chronic morphine treatment.  D-
Ser was shown to augment slightly but significantly in the rat forebrain areas: striatum, 
hippocampus, and cortex while no significant effect were noticed in the diencephalon, 
midbrain, pons-medulla, and cerebellum.[88] 
With a column-switching HPLC system, Hashimoto et al. studied whether D-Ser 
to total serine ratio in CSF was altered in first episode and drug-naïve schizophrenic 
patients.  It was found this ratio was significantly lower in 25 male first episode and drug-
naïve schizophrenic patients than that of 17 age-matched male healthy subjects, 
suggesting the abnormal synthetic or metabolic pathways of D-Ser in the brain of drug-
naïve patients.[89]  In a more recent study, plasma levels of D-Ser were compared 
between patients with schizophrenia and healthy controls as well as during the clinical 
course of schizophrenia.  It was found that plasma D-Ser levels of schizophrenia patients 
were higher than those of healthy controls.  In addition, the increase of D-Ser levels 
seemed to be related with improvements of clinical symptoms.[90] 
Using Marfey’s reagent derivatization followed by C18 column separation, Fuchs 
et al. measured D-Ser concentrations in cerebrospinal fluid of healthy children and those 
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with a defective L-Serine biosynthesis.  This study elucidated possible roles of D-Ser in 
human central nervous system development.  Healthy children demonstrated high D-Ser 
level immediately after birth while the levels were non-detectable in children with 
deficiency.  L-Ser therapy restored D-Ser concentration and interestingly, when L-Ser 
was supplied prenatally, a nearly normal D-Ser concentration was observed at birth of 
patient and the clinical phenotype was normal (Table 2.1).[91]   
2.5  Conclusions 
The remarkable increase in our understanding of D-AA distribution, function in 
the brain as well as their clinical significance is, in many ways, a result of combining 
existing and newly-developed bioanalytical approaches with novel experimental 
strategies.   
Choosing the appropriate techniques for these measurements is important. CE-LIF 
is well suited suitable for single cell analysis due to their compatibility with minute 
sample size and excellent sensitivity provided by LIF detection. Single cell measurements 
can aid neuroscience studies because of the heterogeneity in function and chemical 
composition of even adjacent neurons.  In addition, the significance of immunostaining in 
relating morphological structures to D-AA distribution and subcellular localization is 
widely recognized.  Thus while older than other approaches, it is not likely to be replaced 
by other techniques.  Of course, immunostaining may not be most appropriate for 
quantifying multiple D-AAs within a defined brain tissue.  Therefore, a thorough 
understanding of the questions to be answered via D-AA measurements is necessary to 
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ensure that the most appropriate bioanalytical tool is selected from the extensive tool box 
packed by the analytical community. 
The growth in knowledge of D-AA functions in the brain has prompted a new 
range of questions that require novel techniques with better sensitivity, selectivity, 
reliability as well as enhanced temporal and spatial resolution.  The development of 2D-
HPLC system overcame the challenge of peak co-migration, which frequently occurs due 
to the complexity of brain samples.  As a result, targeted D-AA can now be detected 
without ambiguity and quantified reliably.  Moreover, the newly designed enzyme-linked 
microbiosensor is miniaturized, obtains a 2 s temporal response and 16 nM in vivo 
detection limit.[73]  There is no question that our understanding of D-AAs in the brain is 
being driven by such technology advances, and that as more detailed questions are asked, 
scientists continue to push the analytical tools.   
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2.7 Tables and figures 
 
Figure 2.1.  Individual Aplysia californica neurons have different levels of D-Asp. (a) 
Electropherograms of single neurons from neuronal clusters in cerebral ganglia; some 
peaks are truncated. (b) D-Asp percentage to total Asp in different neurons. F = F-cluster 
top-layer neuron; C = C-cluster top-layer neuron; G = G-cluster neuron; MCC = 
metacerebral cell; OGT = optical ganglion top-layer neuron. (Adapted from ref. [32] with 
permission.) 
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Figure 2.2.  Diagram of the CE system highlighting the nanovial sampling system, the 
postcolumn fraction collector, and the complementary detection modes of LIF and 
radionuclide detection. (Reprinted with permission from (Page, J.S., S.S. Rubakhin, and 
J.V. Sweedler, Single-neuron analysis using CE combined with MALDI MS and 
radionuclide detection. Analytical Chemistry, 2002. 74(3): p. 497-503). Copyright (2002) 
American Chemical Society.) 
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Figure 2.3.  A) Diagram of the MD-CE interface.  B) Effect of veratridine on 
extracellular D- and L-Ser concentrations in rat striatum. Online MD-CE was used to 
monitor D-Ser (left) and L-Ser (right) concentrations in rat striatum. CE analyses were 
performed every 22 s. Black bar denotes the 3-min period (corrected for time to travel to 
the detector) where artificial CSF (aCSF) perfusing the probe was changed to aCSF 
spiked with 100 µM veratridine. Smaller peak (indicated by v) is an artifact that occurs 
when the valve is switched to introduce the drug-containing aCSF into the line. Larger 
peak (indicated by asterisk) corresponds to veratridine-induced d-or l-serine release. 
Dashed lines mark se of 3 replicate measurements. (Adapted from ref. [28, 36] with 
permission.) 
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Figure 2.4.  A) Flow diagram of the 2D-HPLC system for the determination of Ser and 
Ala enantiomers. M, Mobile phase; DG, degasser; P, pump; AS, auto sampler; CO, 
column oven; D, fluorescence detector; CS, column-switching valve; W, waste.  B) 
Reversed-phase separation and the continuously interlinked enantiomer separation of 
NBD-Ser (A) and NBD-Ala (B) using Sumichiral OA-2500S in the serum of 
dY/DAO+/+ mice. The fractions indicated by gray bars (60µL, 120 s) were online 
collected to a loop and transferred to the enantioselective column.  (Adapted from ref. [53] 
with permission.) 
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Figure 2.5.  Design of the biosensor. (A) Photomicrograph of the tip of an RgDAAO 
microbiosensor. The enzymatic layer appears as a translucent yellow membrane. (B) 
Schematic RgDAAO microbiosensor. A platinum wire is covered with a layer of PPD 
and an enzymatic membrane of RgDAAO. (C) Enzymatic reaction allowing D-serine 
detection at the microbiosensor: D-serine is oxidized into hydroxypyruvate by RgDAAO 
with equimolar production of H2O2 that diffuses through the PPD layer and is oxidized by 
the platinum wire. H2O2 oxidation gives rise to two electrons detected by the patch-clamp 
amplifier.  (Reprinted with permission from (Pernot, P., J.P. Mothet, O. Schuvailo, A. 
Soldatkin, L. Pollegioni, M. Pilone, M.T. Adeline, R. Cespuglio, and S. Marinesco, 
Characterization of a yeast D-amino acid oxidase microbiosensor for D-serine detection 
in the central nervous system. Analytical Chemistry, 2008. 80(5): p. 1589-1597.) 
Copyright (2008) American Chemical Society.) 
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Figure 2.6.  Ca
2+
-dependent release of D-serine from astrocytes measured by 
DAAO/HRP/luminol assay. (A) Luminol-derived chemiluminescence (LDCL) trace 
shows D-serine release in response to (S)-α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) (black arrow) in control conditions (normal calcium), in 
extracellular calcium-free solution (ECFS) (0 Ca
2+
/2 mM EGTA), in high Ca
2+
-
containing medium (5 mM), or after intracellular Ca
2+
 chelation with 1,2-bis(2-
aminophenoxy)ethane-N,N,N’,N’-tetraacetateacetoxymethyl ester (BAPTA-AM) (5 µM; 
1 h). Application of the ionophore A23187 (open arrowhead; 10 µM) induced a slow and 
long increase of chemiluminescence. (Scales: 9 fmol per 5 and 20 s.) (B) Statistical 
histogram of the different pharmacological manipulations during AMPA stimulation. (C 
and D) Effect of thapsigargin (10 µM; 20 min) on the response induced by t-ACPD (100 
µM). Data are mean ± SEM of n ≥ 3 independent experiments. **, P < 0.01; ***, P < 
0.001, one-way ANOVA plus Scheffé test.  (Adapted from ref. [76] with permission.) 
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Figure 2.7.  D-Serine localizes to neurons and astrocytes in the brain. (A–C) Staining for 
D-serine in neurons of several layers of the cerebral cortex (Ctx) of a P9 rat.  CC = 
corpus callosum.  D) Glial staining for D-Ser in the corpus callosum.  (Adapted from ref. 
[46] with permission.)  
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Figure 2.8.  Small synaptic-like vesicles contain D-serine.  Primary astrocytes were 
transfected with eGFP-Sb2 (A) and GFP-Cb (B).  Then, cells were double labelled with 
antibodies against D-Ser (red) and GFP (green).  The merged images show in yellow the 
colocalization of D-Ser with eGFP-Sb2 (A) and eGFP-Cb (B) throughout the cell 
cytoplasm.  The zoom insets are representative of the distribution of labeling observed in 
the cells analyzed. Arrows indicate double-labeled structures, arrowheads indicate 
membrane or juxtamembrane eGFP-Sb2/Cb. n, nucleus. Scale bars: 10 µm.  (Adapted 
from ref. [87] with permission.) 
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Table 2.1.  D-Ser, L-Ser, and Gly concentrations and percentage D-Ser of total Ser, 
percentage Gly of the sum of Gly and L-Ser, and ratio of D-Ser to Gly in CSF of patients 
with 3-phosphoglycerate dehydrogenase deficiency before and after L-Ser therapy.  
Patients 1, 2, and 4 received oral postnatal L-Ser supplementation on diagnosis. Due to 
adverse effects, L-Ser dosage was lowered in patient 4 at the age of 1 year. Unfortunately, 
no pretreatment sample of patient 1 was available. Patient 3 received prenatal therapy by 
maternal supplementation with oral L-serine. The first measurement was performed on 
her day of birth. 
a
 Number of CSF samples available for analysis.  (Adapted from ref. [91] with 
permission.) 
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Chapter 3 
Investigating D-Aspartate Release in the Aplysia 
Californica Central Nervous System 
Notes and Acknowledgements 
This chapter is adapted from a paper entitled “Synthesis, accumulation, and 
release of D-aspartate in the Aplysia californica CNS” by Scanlan, C., T. Shi, N.G. 
Hatcher, S.S. Rubakhin, and J.V. Sweedler that was published in Journal of 
Neurochemistry, 2010. 115(5): p. 1234-1244.[1]  
This project was initiated by Cory Scanlan, and I specifically developed the 
method for measuring D-Aspartate (D-Asp) release from Aplysia californica.  I designed 
and performed the experiments of measuring D-Asp release stimulated by elevated 
extracellular potassium.  Experiments from Stanislav Rubakhin and C.S. measuring D-
Asp uptake from the published study are not reported; release results using another 
stimuli and different methods (solid phased extraction (SPE) bead technique) are reported 
here with the purpose of providing an informative context of the whole project. S.R. 
provided training on dissection and always offered helpful discussions whenever needed. 
The manuscript was written by all coauthors.  The project described was supported by 
Award No. CHE-05-26692 from the National Science Foundation (NSF), Award No. P30 
DA018310 from the National Institute On Drug Abuse (NIDA) and by Award No. 
5RO1NS031609 from the National Institute of Neurological Disorders and Stroke 
(NINDS). 
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3.1  Introduction 
It had been long presumed that amino acids, so vital to organismal function, 
predominantly occurred in the L-form, especially in higher animals.  This view persisted 
for decades, even though a variety of D-amino acids (DAAs) were reported since the 
1930s in mammalian tissues,[2] intriguing many when they were observed in human 
tumors.[3, 4]  Hundreds of studies have now documented the widespread occurrence of 
DAAs in animals.  Nevertheless, DAA function in higher organisms remained enigmatic 
until fairly recently, when the role of D-serine as a co-agonist of the NMDA receptor,[5, 
6] and its participation in gliotransmission [7] were established.  These observations, 
combined with additional available experimental evidence, support the likelihood that 
other endogenous DAAs also have physiological role, specifically, D-Asp,[8, 9] D-
alanine,[10, 11] D-glutamate,[12, 13] and D-proline.[14] 
Of these, D-Asp is one of the most studied endogenous DAAs in Metazoan.[6, 8, 
9, 13-17]  It has been detected in a wide variety of species and is present in the nervous 
system of both vertebrates and invertebrates.  For example, within mollusks, free D-Asp 
has been found in the nervous tissue of the Cephalopoda species Octopus vulgaris, Loligo 
vulgaris, and Sepia officinalis;[18] in the buccal ganglia of the opistobranch mollusk 
Aplysia fasciata;[19] in several ganglia of Aplysia californica;[8, 20, 21] and Aplysia 
limacine,[22] as well as in the reproductive glands of O. vulgaris.[18, 23] 
Interestingly, D-Asp appears at relatively high levels during embryonic 
development throughout Metazoan, but the concentration decreases to much lower levels 
in adult animals.  In vertebrates, high D-Asp concentrations occur in the developing 
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retina and CNS of chickens,[24] rats,[25, 26] lizards,[27] frogs,[16] and humans.[28]  D-
Asp drops to trace levels in most animal tissues after maturation, exceptions being 
specific endocrine and exocrine systems.  In adult rats, for example, D-Asp has been 
measured in significant quantities in the testes and in the adrenal and pineal glands,[29, 
30] with concentrations in these tissues reaching up to 40% of the free Asp. 
Despite these reported observations, the functions of D-Asp are not established; 
however, progress is being made.  Indirect evidence demonstrates that changes in D-Asp 
levels are correlated with disease state [31] and similar to D-Ser, it is found in 
mammalian neurons during development.[28, 31]  In an exciting recent report, Kim et al. 
showed that D-Asp is involved in adult mouse neurogenesis, playing a role as a trophic 
factor influencing dendritic development.  Clearly, more studies are required to 
understand its role in the adult animal.[32] 
We and others have hypothesized that D-Asp may function as a neurotransmitter 
or hormone.[8, 22, 26]  However, confirmation of a physiological role for D-Asp as a 
signaling molecule requires that several crucial characteristics be demonstrated: presence 
in a pre-synaptic neuron, activity-dependent release, generation of an effect in the post-
synaptic cell via specific cellular mechanisms, and inactivation of the molecular signal by 
uptake or catabolism.  To examine the function of D-Asp in morphologically documented 
neuronal networks, we have selected the well-characterized neurobiological model, A. 
californica.  For many years, this marine slug has been used in studies linking 
neurochemical pathways to function, and thus, it is an excellent choice for our current 
investigation.  In our prior analyses of the A. californica CNS, we observed significant 
quantities of D-Asp in the C-, F-, and G-clusters of the cerebral ganglia, with over 85% 
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of the free Asp present in the insulin-producing neurons of the F-cluster being in the D-
form.[8]  D-Asp is actively transported along the pleural-abdominal connective in a 
colchicine-dependent manner and induces electrophysiological responses in several 
neurons.  These observations, along with the results of a single-cell study,[21] 
demonstrate that D-Asp is present in A. californica neurons and may play roles in cell-to-
cell signaling.  
Here, we continue these earlier investigations by studying the stimulated release 
of D-Asp.  Briefly, we employ two different sample collection and sample preparation 
methods.  One is by directly collecting extracellular environment without bias.  We then 
develop a protocol using liquid-liquid extraction method to specifically extract amino 
acids out while leave salt behind.  Another is using SPE bead sampling technology used 
in previous peptide studies by our group, which allows more defined analyses in terms of 
spatial resolution.  Our findings showed that the stimulation-dependent release, along 
with other data collected on D-Asp biosynthesis and uptake (not presented here) prepared 
D-Asp being a signaling molecule involved in neurotransmission and/or neuromodulation 
within the A. californica nervous system. 
3.2  Experimental procedures 
3.2.1  Reagents and solutions 
We prepared 500 mL of 50 mM borate buffer (pH 9.4) by dissolving 2.38 g of 
sodium borate (Na2B4O7·10H2O) (Sigma–Aldrich, St. Louis, MO, USA) in 456 mL of 
ultrapure de-ionized (DI) water (Milli-Q Ultrapure Water Filtration Systems; Millipore, 
Bedford, MA, USA) and mixing with ~44 mL of 0.2 M NaOH; this solution was used in 
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sample preparations and as a sheath flow buffer, unless otherwise noted.  The separation 
buffer solution consisted of 20 mM of -cyclodextrin (-CD) and 50 mM of sodium 
dodecyl sulfate (SDS) in 50 mM of borate buffer (pH 9.4) and 15% methanol (V/V).  
Naphathalene-2, 3-dicarboxaldehyde (NDA) was from Molecular Probes (Eugene, OR, 
USA).  As indicated in several cases, a citric acid sheath buffer (25 mM, pH 2.5) was 
used that was made by dissolving 5.25 g of citric acid monohydrate (C6H8O7·H2O; 
Sigma–Aldrich) in 1.0 L of ultrapure DI water (ELGA Purelab Ultra water system; 
USFilter, Lowell, MA, USA), and titrating to pH 2.5 using 0.10 M NaOH.  Other 
reagents were obtained from Sigma–Aldrich at the highest purity available.  Solutions 
were filtered through 0.45 m Acrodisc syringe filters (Gelman Laboratory, Ann Arbor, 
MI, USA) before use.  Solid-phase extraction beads (~40 μm diameter) were obtained 
from Waters (Waters Oasis HLB, Milford, MA, USA).  
3.2.2  Capillary electrophoresis instrument 
There were two CE systems used in this project.  The analyses of samples 
prepared by SPE technique were conducted on the first system.  The second system was 
employed on the measurement of samples prepared by directly collecting extracellular 
medium followed by solvent extraction. 
The first system was a lab-assembled CE-LIF system described previously,[33] 
converted to a 457.9 nm excitation wavelength by adapting the Argon Ion laser (Melles 
Griot, Carlsbad, CA), focusing lens and optics.  Analytes were separated in a 65–75 cm 
long, 50 m ID/360 m OD fused-silica capillary (Polymicro Technologies, Phoenix, 
AZ).   
 65 
 
The second system was a previously described, laboratory-built CE-LIF 
system,[34] converted to a 457.9-nm excitation wavelength by adapting the Argon 
Krypton mixed laser (Coherent, Santa Clara, CA, USA), focusing lens and optics.  The 
schematic is shown in Figure 3.1.  Analytes are separated in an 86 cm long, 50 µm 
ID/360 µm OD fused-silica capillary, with an effective length of 50 cm.  The separation 
voltage is set at 20 kV.  The separation buffer solution consists of 20 mM of β-
cyclodextrin (β-CD) and 50 mM of sodium dodecyl sulfate (SDS) in 50 mM of borate 
buffer (pH 9.4). 
3.2.3 Buccal, cerebral and pleural ganglia isolation 
A. californica (200–300 g) were obtained from Charles Hollahan (Santa Barbara, 
CA, USA) and kept in an aquarium containing continuously circulating, aerated and 
filtered sea water (Instant Ocean, Aquarium Systems Inc., Mentor, OH, USA) at 14–15°C 
until used.  Animals were anesthetized by injection of isotonic MgCl2 (~30 to ~50% of 
body weight) into the body cavity.  The cerebral and buccal ganglia were dissected and 
placed in artificial sea water (ASW) containing (in mM): 460 NaCl, 10 KCl, 10 CaCl2, 22 
MgCl2, 6 MgSO4, and 10 HEPES (pH 7.8), or in ASW-antibiotic solution: ASW 
supplemented with 100 units/mL penicillin G, 100 g/mL streptomycin, and 100 g/mL 
gentamicin (pH 7.8).  
To improve isolation of cellular clusters and individual neurons, the ganglion 
sheaths were digested enzymatically by incubating the ganglia in 1% protease (Type IX: 
Bacterial; Sigma–Aldrich) ASW-antibiotic solution at 34 °C for 1–2 h depending on 
animal size and season.  Next, the ganglia were washed in fresh ASW.  For several 
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measurements, the total protein has been determined to correct for animal to animal 
variations in the ganglia. 
3.2.4 Capillary electrophoresis (CE)-laser induced fluorescence (LIF) 
cerebral ganglion KCl-stimulated release analysis  
The cerebral ganglia were pinned down in a small ~450 µL well.  The ganglia 
were allowed to rest in ASW for > 1.5 h, and then stimulated by increasing the 
extracellular potassium concentration to 53 mM for 20 min.  Aliquots (200 µL)  of 
extraganglionic media were collected before, during and after the KCl stimulation.  Three 
washes of the ganglia were made after the KCl stimulation and before collection of the 
last sample.  Each 200 µL was divided into five 40 µL aliquots in PCR vials and stored 
frozen until the CE-LIF investigation.  The details of sample collection procedure are 
described in Figure 3.2. 
The 40 µL aliquots were dried in the oven overnight and reconstituted with 5 µL 
water or 5 µL internal standards containing 1 µM D-Asp.  The addition of internal 
standard allowed accurate determination of extracellular D-Asp and L-Asp levels and 
reduces methodological uncertainties.  KCN and naphathalene-2, 3-dicarboxaldehyde 
(NDA) solutions were added to the reconstituted samples and the reactions were allowed 
to continue for 20 min in the dark to form N-substituted 1-cyanobenz[f]isoindole amino 
acid (CBI-AA).  The large amount of inorganic salts in these samples created issues with 
CE when the solutions were concentrated; thus, the salts were removed via extraction.   
Specifically, HCl solution was added to the reaction mixture to adjust the pH and the 
resulting neutrally charged CBI-AA was extracted into CH2Cl2.  The lower layer was 
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placed into a PCR tube and the extraction process was repeated three times.  The 
combined collected organic layer was dried and reconstituted with buffer.  The samples 
were then assayed via CE as described.   
3.2.5 F-cluster ionomycin-induced release analysis by CE-LIF  
A microvial containing SPE beads and releasate was placed in the injection port 
of the multichannel CE-LIF instrument.  Two microliters of 8 mM NDA and 2 μL of 20 
mM KCN in 50 mM borate buffer (pH ~9.2) were added to the microvial to elute and 
derivatize the collected releasate analytes.  Derivatization was allowed to continue for 30 
min at which time nearly all the solution in the microvial had evaporated.  Once dry, 0.5 
μL of 50 mM borate buffer was added to the vial, and the sample was then 
hydrodynamically injected into the system by lowering the outlet end of the capillary 15 
cm below the inlet end for 30 s (injecting ~7.6 nL).  Each sample was analyzed by CE-
LIF at 14 kV with an average current of 44 μA.  Running buffer was 50 mM borate (pH 
9.4), with 20 mM -CD and 50 mM SDS. 
3.3 Results 
3.3.1 Liquid-liquid extraction method optimization 
A. californica is a fantastic model in terms of neuroscience investigations due to 
its well-characterized nervous system and large accessible neurons.   However, as it is a 
sea creature, experiments such as release measurements have to be conducted in sea 
water to maintain the cell viability.  This renders difficulty in sample preparation step as 
most analytical separation techniques are not compatible with this high salt concentration.  
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Therefore, the liquid-liquid extraction method was developed and optimized to extract 
and concentrate amino acids while removing most of the inorganic salts.  
A mechanism of pH-mediated solvent extraction of CBI-Asp was developed as 
follows.  First, the AAs in the samples were allowed to react with NDA at pH 9.4.  The 
PKa values of the COOH group, amino group and COOH as R group are 1.88, 9.6, 3.65 
respectively and PI equals 2.77 (Figure 3.3).  At these conditions, the –COOH groups in 
both moieties were deprotonated, so that the targeted analyte partitions into the aqueous 
media.  Subsequently, the pH value was modified to near the PI of Asp, therefore the two 
–COOH groups were partially charged while the amino group was protonated and 
positively charged.  At this point, the CBI-Asp partitions into organic phase while most 
inorganic salts are left in aqueous phase.  
The detailed procedure of CBI-Asp extraction for biological samples with organic 
solvent is illustrated by Figure 3.4.  Optimization of both the choices of organic solvent 
and final sample solution pH employed exactly the same procedure as that of biological 
sample preparation.  Choosing an appropriate organic solvent for solvent extraction was 
the very first step as this solvent must satisfy several criteria. The first criterion is that it 
has to be immiscible with water because the purpose is to leave the salts behind in the 
water.  The second is to make the evaporation of the phase faster.  Although CBI-AAs are 
relative stable, they are light sensitive.  The less the time spent on drying the sample, the 
better the preservation of the CBI-AAs.  Last but not least, the polarity of organic solvent 
needs to match that of CBI-Asp in order to achieve high extraction efficiency of CBI-Asp 
but no other derivatized AAs or peptides.   
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The organic solvent being tested included ethyl acetate, methylene chloride, 
hexane, butyl acetate, chloroform and dichloromethane.  As the derivatized product of 
Asp, CBI-Asp, is a green fluorescence color; the extraction efficiency of different organic 
solvents can be compared by observing the strength of color partitioned into the organic 
layer.  Dichloromethane was finally chosen as the solvent to be used in liquid-liquid 
extraction procedure due to its high extraction efficiency and ease to evaporate.    
The desired pH was chosen based on the CBI-Asp peak intensity while the pH of 
the standard solutions were modified from around 1-4 by adding different volume of HCl.  
Due to the small size of sample (~40 µL), it was rather hard to accurately measure the pH 
after adding HCl.  So although the exact final pH was not known, the amount of HCl 
added in could be easily quantified and controlled.  The optimal extraction efficiency was 
achieved when 0.3 µl 5 M HCl solution was added to the reaction mixture.  So it was 
used for all the sample preparation process.  Through this solvent extraction process, the 
peak intensity of Asp could be increased up to 20 fold.  Moreover, the peak distortion 
caused by high salt was also eliminated (Figure 3.5).  
3.3.2 Liquid-liquid extraction method validation 
When measuring D-Asp release from whole ganglia, it is desired that the amount 
of D-Asp collected can be compared from one experiment to another.  Or it would be 
difficult to know whether D-Asp is truly secreted during stimulation and how much is 
released during one event.  However, because the solvent extraction protocol presented 
earlier is not a quantitative method due to the difference of extraction efficiency, a 
quantitative method needs to be developed and validated. 
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One way to make the method quantitative was to induce D-Asp itself as an 
internal standard.  A prerequisite was that one needed to make sure that the ratio of D-
Asp versus L-Asp after liquid-liquid extraction process represented the ratio of them in 
the original sample.  Different ratios of authentic D/L-Asp standards were mixed and the 
samples underwent exactly the same sample preparation process as real samples.  And the 
results presented in Figure 3.6 showed that the solvent extraction procedure didn’t affect 
the ratio of D/L-Asp in the solution.  We further validated the method by preparing blank 
control (ASW only) using exactly the same procedure to make sure that there were no 
contamination (Figure 3.7).  
Appropriate amount of D-Asp standard was added into samples as internal 
standard (IS) at the very beginning after the releasates were collected.  The samples were 
run twice, with IS or without and electropherograms of the two were aligned based on 
peak height/ peak area of L-Asp, whose levels were the same between two samples.  This 
step could give a peak height/ peak area of the IS.  The electropherograms of before and 
after stimulation samples were then aligned again based on the peak height/peak of IS, 
which was kept constant from one sample to another.  As a result, a quantitative 
measurement of D-Asp can be achieved by calculating the relative peak height of D-Asp 
total peak to D-Asp internal standard.      
3.3.3 Secretion of D-Asp from whole ganglia or F-cluster cells 
Establishing activity-dependent release from neurons is an important criterion for 
determining if a compound functions as a neurotransmitter and/or neuromodulator. 
Increase in the extracellular concentration of both endogenous D-Asp and L-Asp was 
observed upon stimulation of intact cerebral ganglia by elevated potassium ion 
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concentrations in the media surrounding the ganglia (Figure 3.8). Interestingly, while 
Asp-levels increased, the ratio of the enantiomer differed from experiment to experiment 
(Figure 3.9), with instances when D-Asp (experiment #2) or L-Asp (experiment #3) 
contributed most to this increase. This variability differs from the range of levels of D- 
and L-Asp present in cells and tissues and, therefore, may indicate intrinsic regulation of 
D-Asp release.  
To further refine the information on D-Asp release, we studied the secretion of D-
Asp from two cerebral ganglion neurohemal regions—the anterior tentacular and upper 
labial nerves—using bead sampling technology [35, 36] (Figure 3.10) with CE-LIF 
measurements of the collected releasates. Our previous experiments showed that cerebral 
F-cluster cells have high levels of D-Asp present in their cell body.[8] Many of these 
neurons send their processes to the neurohemal areas located at the bases of the anterior 
tentacular and upper labial nerves, as well as the cerebral commissure.[37, 38]  Larger 
Aplysia insulin-producing neuroendocrine cells have their terminals located in the first 
two areas.[37] We detected a small amount of both D- and L-Asp in prestimulation 
samples, suggesting a small, constitutive secretion rate (Figure 3.11). Following 
stimulation with 10 μM of the calcium ionophore, ionomycin, a marked increase in D-
Asp release is detected, suggesting that secretion of the enantiomer into the hemolymph 
does in fact occur and is, moreover, induced by calcium entry. In one set of 
experiments, >160 pmol of D-Asp was collected after stimulation with ionomycin from 
the F-cluster cells. These data support the concept of Ca
2+
-dependent release of D-Asp 
from neurons, consistent with vesicular exocytosis of both enantiomers.   
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3.4 Discussion 
3.4.1 D-Asp release 
Several groups described D-Asp release from brain tissue upon chemical or 
electrical stimulation in mammalian endocrine tissues using radioactive labeling [39-41] 
and HPLC.[17, 42]  Both KCl and acetylcholine-induced D-Asp release were more 
pronounced than that of L-Asp in adrenal slices, and only D-Asp (but not L-Asp or L-Glu) 
was shown to be released from rat adrenal gland when stimulated with nicotine.[42] In 
the rat brain, electrically evoked [3H]-D-Asp release from hippocampal slices mimics the 
release of L-Glu.[41]  Similarly, electrical field-induced D-Asp release has been 
demonstrated in cerebral cultures and is not only Ca2+-dependent but also sensitive to 
synaptic vesicle toxins (including the relatively specific V-type H+-ATPase inhibitor), 
suggesting that D-Asp can accumulate in synaptic vesicles.[43]  Studies on different 
animal models have also shown that D-Asp is stored in secretary granules,[17, 44] 
actively transported in nerves in a colchicine-dependent manner,[8] present in 
synaptosomes [44] and released in a Ca2+-dependent manner, similar to that of 
dopamine.[17]  However, these experiments are not often at the level of a single cell, but 
rather, are made using large populations of cells containing multiple cell types (e.g., 
neurons, glia, etc.), thereby making it difficult to differentiate the neuronal contribution to 
D-Asp release.   
Our findings show that F-cluster cells are capable of releasing a relatively high 
quantity of D-Asp at A. californica neurohemal areas.  Released D-Asp may influence 
nearby neuronal terminals, sheath and vasculature cells at these locations, as well as distant 
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targets via a hormonal role.  It is particularly intriguing that different chemical stimuli 
induce Asp release where the ratio of D-Asp to L-Asp varies.  For example, ionomycin 
stimulation results in the predominant release of D-Asp, and was also found to be a more 
potent stimulus compared to an elevated potassium concentration for D-Asp release from A. 
limacina synaptosomes.[44]  Thus, it appears that D-Asp and L-Asp release from the same 
physical location can be independently varied depending on a number of factors.  
3.5 Conclusions 
In this chapter, we report an off-line coupling of pH-mediated concentration and 
extraction of amino acids with CE to overcome the challenge of measuring extremely 
diluted D-Asp molecules from samples containing high levels of salts.  With this method, 
the separation of amino acids from other biological compounds, as well as removal of salts 
in the same matrix was realized.  
This new method along with the bead sample technology we have developed earlier 
provided a good toolset to study D-Asp release from whole Aplysia ganglia as well as 
specific locations using both KCl and ionomycin as stimuli. 
The advantage of combining A.californica CNS studies with small volume analytical 
methods is the ability to study D-Asp dynamics at the neuronal cluster or even single neuron 
level. Information on the formation, uptake/accumulation (results not presented here) and 
release,of D-Asp in the A. californica nervous system indicates it plays a likely role in cell-
cell signaling and justifies follow-up physiological studies on D-Asp function in neuronal 
systems. Additional work is now aimed at determining the specific enzymes involved in D-
Asp synthesis.   
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3.7 Tables and figures 
 
Figure 3.1.  The schematic of the CE-LIF detection system.  Analytes are separated in an 
86 cm long, 50 µm ID/360 µm OD fused-silica capillary, with an effective length to the 
detector of 50 cm.  The separation voltage is set at 20 kV.  The separation buffer solution 
consists of 20 mM of β-cyclodextrin (β-CD) and 50 mM of sodium dodecyl sulfate (SDS) 
in 50 mM of borate buffer (pH 9.4). Reprint with permission from (Floyd, P.D., L.L. 
Moroz, R. Gillette, and J.V. Sweedler, Capillary electrophoresis analysis of nitric oxide 
synthase related metabolites in single identified neurons. Anal. Chem., 1998. 70(11): p. 
2243-7.) Copyright (1998) American Chemical Society.) 
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Figure 3.2.  Schematic representation of collecting extraganglionic media after KCl 
stimulation.  Ganglia were allowed to rest from at least one hour before pre-stimulation 
samples were collected.  Stimulated releasates were collected after 20 min stimulation of 
40 mM extracellular concentration.   
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Figure 3.3.  Reaction of NDA derivatizing primary amines.  The bottom figure shows that 
the pH of CBI-Asp can be manipulated close to the pI of Asp, so the molecules of CBI-
Asp can mostly have a neutral charge. 
  
CBI-Asp 
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Figure 3.4.  Schematic view of the solvent extraction procedure.  The purpose of 
performing this step is to concentrate the extremely diluted D-Asp while leave the salt 
behind.  The lower layer is organic phase containing CBI-Asp and the upper layer is 
aqueous layer containing salts.  
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Figure 3.5.  Representative electropherograms of stimulated samples with or without 
undergoing solvent extraction procedure.  The top trace shows clear D/L-Asp peaks with 
a Gaussian shape, while the bottom trace shows no recognizable peaks.  
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Figure 3.6.  Method validation of solvent extraction protocol.  a) Calibration curve 
showing the measured D/ (D+L)-Asp peak ratio of samples undergoing solvent extraction 
process versus the ratio of amount in original sample.  The linearity and slope of one 
suggests that D/L-Asp is extracted into the organic phase to the same extent at all levels.  
b) Representative peak profiles plotted in the calibration curve. 
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Figure 3.7.  Representative electropherograms of blank control versus biological samples. 
The comparison of control (middle trace) and sample (bottom trace) demonstrates the 
negligible amount of contaminations from blank, which would not affect the 
measurement of D/L-Asp from biological samples. 
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Figure 3.8.  Elevated extracellular concentrations of potassium ions potentiate release of 
D/L-Asp from the cerebral ganglia.  Representative electropherograms show cerebral 
ganglion releasate before KCl stimulation (left) and after KCl stimulation (right).  In both 
cases, the black trace shows the original sample and the red trace shows the sample 
spiked with 1 µM D-Asp, used to calibrate the signal levels.  Arrows indicate the increase 
in D-Asp signal because of the addition of standard and the change because of potassium 
ion stimulation (labeled standard and stimulation, respectively).  Adapted from 
“Synthesis, accumulation, and release of D-aspartate in the Aplysia californica CNS” by 
Scanlan, C., T. Shi, N.G. Hatcher, S.S. Rubakhin, and J.V. Sweedler that was published 
in Journal of Neurochemistry, 2010. 115(5): p. 1234-1244.[1]  Adapted with permission.  
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Figure 3.9.  Stacked histograms summarizing results from five experiments, with 
statistical data placed in the sixth column.  For each experiment, the extracelluar 
potassium concentration was increased to 53 mM during the 20 min stimulation.  
Adapted from “Synthesis, accumulation, and release of D-aspartate in the Aplysia 
californica CNS” by Scanlan, C., T. Shi, N.G. Hatcher, S.S. Rubakhin, and J.V. Sweedler 
that was published in Journal of Neurochemistry, 2010. 115(5): p. 1234-1244.[1]  
Adapted with permission. 
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Figure 3.10.  Microphotograph of solid phase extraction (SPE) collection beads placed 
upon the anterior tentacular and upper labial nerves of a cerebral ganglion from Aplysia 
californica to collect releasate from neurohemal areas containing terminals of the F-
cluster neurons.  (Inset) Close-up of the SPE beads on the nerves.  Scale bar = 1mm.  
Adapted from “Synthesis, accumulation, and release of D-aspartate in the Aplysia 
californica CNS” by Scanlan, C., T. Shi, N.G. Hatcher, S.S. Rubakhin, and J.V. Sweedler 
that was published in Journal of Neurochemistry, 2010. 115(5): p. 1234-1244.[1]  
Adapted with permission. 
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Figure 3.11.  Capillary electrophoresis with laser-induced fluorescence 
electropherograms of F-cluster releasate collected by solid phase extraction beads.  (a) 
Releasate from F-cluster cells before stimulation.  (b) Releasate from F-cluster cells after 
chemical stimulation with 10 µM ionomycin. (c) Accuracy of L- and D-Asp signal 
assignments is determined via standard addition using both enantiomers.  Adapted from 
“Synthesis, accumulation, and release of D-aspartate in the Aplysia californica CNS” by 
Scanlan, C., T. Shi, N.G. Hatcher, S.S. Rubakhin, and J.V. Sweedler that was published 
in Journal of Neurochemistry, 2010. 115(5): p. 1234-1244.[1]  Adapted with permission. 
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Chapter 4 
Measuring D-Serine in Astrocytic Synaptic-Like 
Vesicles Using Capillary Electrophoresis 
Notes and acknowledgements 
This is a collaborative work between the Mothet group (Université de Bordeaux 
and now located at the Universite Aix-Marseille) and the Sweedler group, as well as 
several other groups including those at the Universität Münster, Université de Lausanne, 
Université Paris, and the Max-Planck-Institut für Biophysikalische Chemie with the work 
being prepared for publication with the title and authors as follows ( “Storage and uptake 
of D-serine into astroglial vesicles specify gliotransmission” by Martineau, M., T. Shi, J. 
Puyal, A.M. Knolhoff, J. Dulong, B. Gasnier, J. Klingauf, J.V. Sweedler, R. Jahn, J.P. 
Mothet, in preparation). This international collaboration has as its goal to answer to 
several outstanding questions related to gliotransmission.  I was responsible for much of 
the analytical chemistry measurements, which includes sample pretreatment, CE analyses 
(with Ann Knolhoff’s help on CE-MS analyses) and related data interpretation.  This 
chapter presents the work I was involved in, and does not include the detailed 
information regarding biochemistry and in situ hybridization which were performed 
mainly by Magalie Martineau and Jean-Pierre Mothet.  However, some of the results 
from these other measurements are included here  in this chapter, in order to provide a 
complete picture of this collaborative work.   
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performed the immunofluorescence staining B.G. and J.P.M. performed the transport 
assays with radiolabelled amino acids (not presented here due to limit of space).  J.K. 
contributed to final experiments and analysis. J.P.M., the advisor of M.M., conceived and 
directed the study.  We acknowledge grant supports from CNRS (JPM), INSERM (JPM), 
Conseil Régional d’Aquitaine (JPM), the National Research Agency (JPM), the U.S.A. 
NSF CHE-1111705 and CHE0526692 and NIH P30DA018310 (JVS). 
4.1 Introduction 
Traditionally, synaptic activity only refers to the signal transmission of 
information from one neuron to another.   It occurs when neurotransmitters, which are 
neuron-derived molecules, are released upon depolarization of the nerve terminal of the 
presynaptic neuron and bind to specific receptors on the postsynaptic neuron.  However, 
neurons are not the only type of cells making up the central nervous system (CNS).  The 
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CNS is composed of both neurons and glia, with glia being by far  more numerous.  The 
numeric preponderance of glia over neurons can be a 4:1 ratio in humans.[1]  The 
traditional model of chemical synapse which only involves neurons needs to be revised 
due to recent findings describing the role of glial cells as a third party of the chemical 
synapse.[2-4]  Anatomically, glia are well positioned to exchange chemicals with neurons 
at synapses, where chemical communication takes place via their fine processes which 
are in close proximity to synapses.[5]  Despite glia’s intimate structural relation with 
neurons, the role of glial cells in chemical synapses was long ignored by 
neurophysiologists who considered them no more than housekeeping cells and only 
supplying nutrients for neurons.  Now there is an emerging concept of the tripartite 
synapse considering glial cells, particularly astrocytes, as dynamic partners of neurons at 
synapses, controlling synaptogenesis [6] and synaptic transmission.[7]   
A possible detailed mechanism of gliotransmission can be described as follows.  
In this model, astroglial cells first sense the level of synaptic activity through the 
interaction of various chemicals with a range of ion channels, transporters or receptors on 
the cell surface.[8, 9]  This event triggers intracellular calcium elevation of glia,[10, 11] 
which induces the release of diverse signaling molecules termed gliotransmitters.  Those 
gliotransmitters in turn regulate synaptic events and neuronal excitability by affecting 
pre- and postsynaptic neuronal elements.[12]  Among those identified gliotransmitters are 
glutamate,[13, 14] adenosine triphosphate (ATP) [15, 16] and taurine.[17]   
Another major glial-derived neuromodulator, D-Ser has been unveiled by the 
studies over the last decade.[18, 19]  The discovery of D-Ser in the CNS revolutionized 
our thinking and forced us to reconsider the long believed fact that only L-isomers of 
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amino acids exist in mammalian tissues and body fluids.  It is known today that higher 
organisms produce D-amino acids and in particular D-Ser.[20, 21]  More importantly, 
works have shown that D-Ser is mainly present at astrocytes,[22] although very low 
levels can be detected in some neurons.[23]  Another intriguing feature of this molecule 
is that it fulfills all criteria to be the major ligand for the strychnine-insensitive glycine-
binding site of the N-methyl-D-aspartate receptors (NMDARs),[19] a key receptor for 
excitatory transmission and cognitive functions.  Activation of NMDARs required 
glutamate and a co-agonist, which used to be thought as glycine.[24]  The evidence of 
high levels of D-Ser present in regions enriched in NMDARs suggests the possibility of 
D-Ser to be an alternative co-agonist for NMDAR activation.   
The biosynthesis of endogenous D-Ser was later reported by Snyder, showing the 
localization serine racemase (SR), an enzyme that synthesizes D-ser from L-Ser, was 
mainly present at astrocytes.[25, 26]  Subsequently, it was demonstrated that selective 
degradation of D-Ser, but not of glycine, by D-amino acid oxidase (DAAO) significantly 
reduced NMDAR-dependent neurotransmission in the hippocampus.[27]  This 
unambiguously indicated that glial-derived D-Ser is an endogenous ligand of NMDARs 
and glial cells can contribute actively to NMDAR-dependent processes in the mammalian 
brain.      
 However, the mechanism of D-Ser release from glia is still not clear.  Do 
astrocytes release signaling molecules, such as D-Ser?  Is the mechanism exocytosis, just 
like how most small molecule neurotransmitters are released from neurons?  And is 
exocytosis of conventional small vesicles?  These questions need to be addressed.  It has 
been proposed that astroglia release D-Ser through a Ca2+- and synaptobrevin 2 (Sb2)-
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dependent mechanism.[28-30]  However, whether the released gliotransmitter originates 
from a cytosolic pool or from secretory organelles (the glia exocytosis hypothesis) 
remains controversial.[31]  An issue with the general acceptance for astroglia exocytosis 
of neuromodulators, like D-Ser or l-glutamate (L-Glu), is that the demonstration of the 
enrichment of these gliotransmitters and their uptake in glia vesicles (GVs) has yet to be 
established. Understanding the molecular mechanisms of the release and uptake of 
gliotransmitters and notably D-Ser is an important step towards explaining the role of glia 
in the neuron-glia synapse. Currently, there is a gap in our understanding of glia 
transmitters.   
Here we address the question of whether D-Ser and other gliotransmitters are 
packaged into vesicles and released via exocytosis similar to most neuron-based signaling 
molecules.  Vesicles have been purified from astrocytes using magnetic beads coupled to 
vesicle specific antibodies.  Immunoisolated Sb2-containing GVs display morphological 
and biochemical features similar to synaptic vesicles (SVs).  In order to measure low 
levels of amino acids within those purified GVs, we use a custom capillary 
electrophoresis system with laser-induced fluorescence detection that has been optimized 
for characterizing chiral amino acid pairs from chemically-complex, small-volume 
samples.  Our analyses results show the existence of a population of GVs which stores D-
Ser and L-Glu, with estimated intravesicular concentrations of ~20 mM.  This level is 
within the acceptable range of the concentration of signaling molecules. While not 
reported here, other results studied the localization, uptake and transport, producing a 
complete and convincing story.  More specifically, when these results  (not completely 
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presented here), we conclude that vesicles in astroglia do exist with the function to store 
and release D-serine, L-glutamate, and most likely other neuro- and gliamodulators. 
 
4.2 Experimental  
4.2.1 Reagents 
We prepared 500 mL of 50 mM borate buffer (pH 9.4) by dissolving 2.38 g of 
sodium borate (Na2B4O7·10H2O) (Sigma–Aldrich, St. Louis, MO, USA) in 456 mL of 
ultrapure de-ionized (DI) water (Milli-Q Ultrapure Water Filtration Systems; Millipore, 
Bedford, MA, USA) and mixing with ~44 mL of 0.2 M NaOH; this solution was used in 
sample preparations buffer, unless otherwise noted.  The separation buffer solution 
consisted of 10 mM of γ-cyclodextrin (γ-CD) and 30 mM sodium dodecyl sulfate (SDS) 
in 75 mM of borate buffer (pH 10.5).  A CE-LIF non-chiral separation condition (50 mM 
borate buffer at pH 8.42) as well as CE-MS was used to verify the quantitation results. 
Naphathalene-2, 3-dicarboxaldehyde (NDA) was from Molecular Probes (Eugene, OR, 
USA).  Methanol was purchased from Fisher Scientific (Fair Lawn, NJ) and formic acid 
was from Thermo Scientific (Rockford, IL).  Other reagents were obtained from Sigma–
Aldrich at the highest purity available. Solutions were filtered through 0.45 m Acrodisc 
syringe filters (Gelman Laboratory, Ann Arbor, MI, USA) before use.   
4.2.2 Capillary electrophoresis instrument 
CE-LIF system 
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The system was a previously described, laboratory-built CE-LIF system,[32] 
converted to a 457.9-nm excitation wavelength by adapting the Argon Krypton mixed 
laser (Coherent, Santa Clara, CA, USA), focusing lens and optics.  Analytes are separated 
in an 86 cm long, 50 µm ID/360 µm OD fused-silica capillary, with an effective length of 
50 cm. The separation voltage is set at 20 kV.  The chiral separation buffer solution 
consists of 10 mM of γ-cyclodextrin (γ-CD) and 30 mM sodium dodecyl sulfate (SDS)  
in 75 mM of borate buffer (pH 10.5).  The non-chiral separation buffer solution consists 
of 50 mM borate buffer at pH 8.42. 
CE-ESI-MS system 
Samples were analyzed by a custom-built CE-ESI-MS platform that was partially 
based on an earlier system.[33]  The signal was converted to 20 kV and was directly 
applied across a 90 cm-long fused silica capillary (40 µm inner diameter (i.d.), 110 µm 
outer diameter (o.d.), Polymicro Technologies, Phoenix, AZ) for electrophoresis 
separations.  This separation capillary was connected to a custom-built coaxial sheath-
flow ESI source.  The sheath liquid (50% methanol with 0.1& formic acid) was supplied 
through the emitter at a 750 nL/min flow rate using a syringe pump.  The separation 
capillary was coaxially fed through the emitter and protruded ~50-80 µm into the Taylor 
cone for stable and efficient ion generation by microelectrospray source.[34] 
4.2.3 Analysis of vesicle contents 
Starting material and immunoisolates were treated with 5% trichloroacetic acid to 
extract the free amino acids as described.[35] Amino acids were determined by a 
laboratory-assembled CE-LIF system using pre-column derivatization with 10 mM 
naphthalene-2,3-dicarboxaldehyde (NDA) and 20 mM KCN for 20 min in the dark. 
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Chiral separation and quantitation (3 or 4 technical replicates) was achieved by 
employing a separation buffer consisting of 10 mM γ-cyclodextrin, 30 mM sodium 
dodecyl sulfate (SDS) and 75 mM borate buffer at pH 10.5.  Quantification results were 
accomplished by establishing calibration curves (Figure 4.1) for each molecule of interest 
within the linear range of the detector.  The samples were diluted accordingly to ensure 
that concentrations of molecules being measured fall in the range of calibration curves.  
A CE-LIF non-chiral separation condition (50 mM borate buffer at pH 8.42) as well as 
CE-MS was used to verify the quantitation results. The laboratory-assembled CE-MS 
instrument and separation conditions were as described previously.[34]   
To verify the D-Ser peak assignment, biological samples were incubated with 
Rhodotorula gracilis D-amino acid oxidase (RgDAAO), which was kindly provided by 
Dr. Pollegioni’s group at the University of Insubria in Italy.  The original concentration 
of RgDAAO was 10.6 mg/ml, and it was diluted 1000 times in 100 mM phosphate buffer 
(pH = 8.25), giving a final concentration of ~10 µg/ml.  The diluted enzyme solution was 
stored on ice to keep the activity of enzyme.  Samples and enzyme solution were mixed 
with 1 to 2 volume ratio.  In control experiments, enzyme solution was replaced by 
phosphate buffer.  Samples were allowed to incubate with RgDAAO overnight at 30 °C.  
Derivatization was performed as described in previous paragraph before CE analyses 
were performed.   
4.2.4 Antibodies  
Monoclonal antibody clone 69.1 against rat synaptobrevin 2 (Sb2) was previously 
characterized.[36]  The antibodies against the following proteins were used: cathepsin D 
(Santa Cruz biotechnology), cellubrevin (Covalab), D-serine (GemacBio), EEA1 (clone 
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14) and GM130 (clone 35) (Transduction Laboratories), Na
+
/K
+
-ATPase and SV2 
(Developmental Studies Hybridoma Bank), PDI (clone RL90, Abcam), serine racemase 
(Santa Cruz Biotechnology and clone 29, BD Biosciences), synaptophysin (clone 7.2), 
TfR (clone H68.4, Invitrogen), vGlut1 and vGlut 2 (Millipore), Glutamine synthase 
(clone SH-B1, Sigma), β3-tubulin (clone TU-20, Chemicon) and glial fibrillary acidic 
protein (GFAP, DAKO).  Rabbit polyclonal antibodies against Serine Racemase, 
SNAP23 and v-ATPase were kind gift of Herman Wolosker (Technion-Israel Institute of 
Technology, Haifa, Israel), Thierry Galli (INSERM, Paris, France) and Nicolas Morel 
(CNRS, Gif-sur-Yvette, France), respectively.  Mouse monoclonal IgG1 was from 
Serotec (France). Secondary antibodies conjugated to horseradish peroxidase and Alexa 
Fluor 488 or 546 were obtained from P.A.R.I.S. and Invitrogen, respectively. 
Biotinylated donkey anti-rabbit antibody was from Jackson Immunoresearch and the goat 
anti-rabbit IgG coupled to 1.4-nm gold particles was from Nanoprobes. 
4.2.5 Cell cultures  
Cultured cortical astroglia cells were prepared from 0- to 4-day-old postnatal 
Wistar rats as previously described.[29]  Cells were plated onto 150 cm² flasks, kept at 
37 °C in a 5% CO2 incubator for 14-20 days.  Astroglia cultures purity (>95%) was 
assessed by immunostaining against the astrocytic marker GFAP. 
4.2.6 Organelle immunoisolation 
The scheme of immunoisolation procedure is presented in Figure 4.2.  All steps 
were carried out at 4-6 °C for western blot and transport analysis or at 0 °C for amino 
acid content analysis.  For the immunoisolation of GVs, cultured astroglial cells were 
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washed, harvested by scraping and resuspended in homogenization buffer (4 mM 
HEPES-KOH pH 7.4, 100 mM K2-tartrate, 2 mM MgCl2, protease inhibitor cocktail 
(Complete EDTA-free, Roche)).  Cells were homogenized using a cell cracker (clearance 
10µm, European Molecular Biology Laboratory, Heidelberg, Germany) and the lysate 
was centrifuged for 10 min at 400 g. Low speed supernatants (LSS) (containing ~1 
mg/ml protein) were incubated with monoclonal antibodies against Sb2 for 2 h under 
rotation and with magnetic beads coupled to protein G (Ademtech) one additional hour.  
The beads were further washed 3 times with homogenization buffer.  Unbound 
membranes in the supernatant and LSS were pelleted by centrifugation at 175,000 g for 2 
h in 80Ti rotor.  All membrane or bead pellets were resuspended in SDS-PAGE sample 
buffer before being processed for gel electrophoresis and immunoblotting with standard 
methods, or in appropriate buffer for further analysis.  Isolations with murine IgG or at 
21 °C were used as a control.  Vesicular amino acid contents were corrected for 
nonspecific adsorption on beads determined by isolating vesicles at 21 °C. 
Immunoisolation of synaptic vesicles was performed following the same protocol, 
with the following modifications.  The rat cerebral cortex of a male Wistar rat (2 months) 
was homogenized with a glass/Teflon homogenizer (10 strokes at 2,500 rpm) in 
homogenization buffer immediately after decapitation.  The homogenate was centrifuged 
for 25 min at 35.000 g.  The resulting supernatant (containing ~3 mg/ml protein) was 
incubated 1 h with anti-Sb2 and 1 h with magnetic beads. 
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4.2.7 Electron microscopy on isolated vesicles  
Immunobeads with bound organelles were fixed in 3% glutaraldehyde in 0.1 M 
sodium cacodylate (pH 7.4) for 1 h at 20 – 22 °C.  After a rinse in 0.1 M sodium 
phosphate (pH 7.4), the beads were embedded in 1% agarose in the same buffer.  Agarose 
blocks were then postfixed for 1 h with OsO4 (1% in phosphate buffer), dehydrated and 
embedded in Epon.  During dehydratation, they were stained en bloc with uranyl acetate 
in 50% ethanol.  Thin sections (~60 nm) were counter-stained with lead citrate and 
examined in a Philips 301 electron microscope. 
4.3 Results 
To uncover the existence of astroglial secretory organelles that store D-serine, we 
carried out a detailed analysis of Sb2-containing vesicles from rat cortical astrocytes.  
Glial organelles were immunoisolated from a low speed supernatant (LSS) of cultured 
astrocytes using the cytoplasmic epitope of the SNARE (soluble N-ethylmaleimide-
sensitive factor attachment protein (SNAP) receptor) protein Sb2 as a bait.[29, 37, 38] 
Electron microscopy analysis revealed that purified Sb2-containing organelles (Figure 
4.3a) are clear round shape vesicles with a homogenous diameter of 40 ± 16 nm (Figure 
4.3b). GVs appear similar in size and morphology to GVs and SVs in situ.[39, 40]  
Control beads coupled to non-immune IgG were devoid of bound membranes, suggesting 
that membrane contamination is negligible.  
Defining D-serine as an exocytically released gliotransmitter requires 
characterizing the amino acid content of purified GVs. Capillary electrophoresis analyses, 
with laser-induced fluorescence as detection method, revealed that vesicle fractions 
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contained D-serine and L-glutamate in amounts that were largely enriched over control 
incubations (Figure 4.4).  
One challenge we have encountered using CE-LIF to measure D-amino acids in 
complicated biological samples was that peak co-migration, although rare, still could 
exist.  In this work, several steps have been taken to ensure an unambiguous 
identification of D-Ser peak and an accurate quantification of all amino acids of interest.  
First step was to incorporate an D-amino acid oxidase (DAAO) enzyme reaction, which 
could specifically convert the amino group on D-Ser to a keto group (Figure 4.5).  As a 
result, D-Ser peak should be removed after enzyme incubation.  The removal of D-Ser 
with Rhodotorula gracilis D-amino acid oxidase (RgDAAO) [28] verified the identity of 
D-Ser (Figure 4.6).  The second step was to take two complementary non-chiral 
separation approaches, using either laser-induced fluorescence (Figure 4.7) as detection 
method or mass spectrometry (Figure 4.8).  The two complementary approaches 
validated our quantitation results of the amino acid content within purified vesicles.  The 
quantitation results of all the amino acids were consistent among different methods, 
except GABA.  The CE-LIF chiral separation method presented a significant GABA peak 
while both two non-chiral methods detected only a trace level (Figure 4.9).  This 
indicated that there was another unknown molecule co-migrating with GABA under the 
condition of chiral separation.  This was an excellent example to show the need of using 
more than one measurement protocols in CE-LIF when analyzing complex biological 
samples.  The quantitation results from three different methods on two CE platforms 
(Table 4.1) agree well, further enhancing the credibility of our quantitation data.  
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We also characterized immunoisolated SVs using CE-LIF analysis.  Isolated SVs 
contained a significant amount of L-glutamate, glycine and γ-aminobutyric acid (GABA) 
(Figure 4.10).  These vesicular neurotransmitters agreed with previous studies.[41]  
Although present in the cortex homogenate, D-Ser was not detected in SVs further 
indicating that neurons may not exocytose D-Ser but release it from a cytosolic pool.[42, 
43]  Accordingly, neuronal D-Ser immunostaining was confined to the soma of neurons 
but was excluded from their distal neuritis or boutons (data not presented here).  The 
retrieval of D-Ser only GVs argues for the existence of a glia-specific transport 
mechanism.  
Assuming similar expression of Sb2 copies in GVs and SVs [44] and taking into 
account the degree of reported colocalisation between the gliotransmitters and Sb2,[29, 
45] we estimated the intravesicular concentration of D-serine and L-glutamate to be ~20 
mM. 
4.4 Conclusions 
It has been previously established that release of gliotransmitters such as L-
glutamate or D-Ser is dependent on Ca
2+
-regulated exocytosis.[28-30, 38, 40, 46]  
However, the vesicular origin of the release gliotransmitter remained controversial.[31]  
Here we provided a direct and unequivocal demonstration that two gliotransmitters, 
namely L-Glu and D-Ser, are stored inside GVs.  The existence of different populations 
of vesicles in glia to store and release one or several gliotransmitters requires further 
investigation.  Our evidence of vesicular release of D-Ser doesn’t exclude the possibility 
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of non-vesicular release mechanism, such as gap junction hemichannels, reversal of 
uptake carriers, which can be responsible for L-Glu release from astrocytes.[31]  
Our approach, combining immunopurification and various analytical chemistry 
techniques, reveals the storage of both D-Ser and L-Glu in a group of astrocytic synaptic-
like vesicles contain both D-Ser and L-Glu.  This evidence, along with other data on D-
Ser vesicular transport (not presented here), support the concept that astrocytes possess 
specific vesicles capable of sequestering and storing D-Ser and Glu as gliotransmitters, 
which undergo calcium-dependent exocytosis and modulate synaptic transmission.  
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4.6 Tables and figures 
 
Figure 4.1.  Representative calibration curves generated for amino acid quantitation using 
CE-LIF.  The linear range is from 0-2000 nM, with three technical replicates. 
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Figure 4.2.  Scheme of immunoisolation procedure.  The same process was performed 
both at 0 °C and elevated temperature 20 °C, when most amino acid contents leak out of 
the vesicles[41].  So samples prepared at 20 °C were used as blank controls to correct for 
nonspecific binding of amino acids onto the beads. 
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Figure 4.3.  Morphological characterization of Sb2-positive GVs.  a) Electron 
micrographs of organelles immunoabsorbed onto beads. Scale bar: 100 nm. Control 
immunopurification (Ctl) shows no bead-bound vesicle.  b) Size distribution of 
immunoisolated vesicles bound to Sb2 beads. The number of vesicles analyzed (total = 
300) is reported within the bars. Black curve represents the Gaussian fit of diameter size 
distribution. 
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Figure 4.4.  Representative electropherograms of immunoisolated glial vesicles (GVs).  
Astrogilal low-speed supernatant (LSS), Sb2-containing vesicles immunoisolated at 
20 °C (leaked GVs) and at 0 °C (Intact GVs) were analyzed by CE-LIF.  
Electropherograms are adjusted to the same scale to facilitate the comparison between 
traces.  Arrows point to the peak of L-Ser (LS), D-Ser (DS), GABA + unknown substance 
(γ*), glycine (G) and L-Glu (E).  
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Figure 4.5.  Reaction of DAAO with D-amino acid.  DAAO can selectively convert the 
amino group on D-amino acids, but not L-amino acids to a keto group.  
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Figure 4.6.  Representative electropherograms of intact vesicle samples treated with (top) 
or without (bottom) DAAO.  Electropherograms are adjusted to the same scale to 
facilitate the comparison between traces.  Arrows point to the peak of L-Ser (LS), D-Ser 
(DS), GABA + unknown substance (γ*), glycine (G) and L-Glu (E).  
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Figure 4.7.  Representative electropherograms of vesicle amino acid content using CE-
LIF with a non-chiral separation method.  To validate quantitation results via CE-LIF 
chiral separation as shown in Figure 4.4, astroglial Sb2-containing vesicles 
immunoisolated at 20 °C (leaked GVs) and at 0 °C (intact GVs) were analyzed using a 
non-chiral CE-LIF method.  Electropherograms are adjusted to the same scale to facilitate 
the comparison between traces.  Arrows point to the peak of Ser (S), GABA (γ), glycine 
(G) and L-Glu (E). 
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Figure 4.8.  Representative data of vesicle amino acid content using CE-MS with a non-
chiral separation method.  To validate quantitation results via CE-LIF chiral separation as 
shown in Figure 4.4, astroglial Sb2-containing vesicles immunoisolated at 20 °C (leaked 
GVs) and at 0 °C (intact GVs) were analyzed using a non-chiral CE-MS method.  
Electropherograms are adjusted to the same scale to facilitate the comparison between 
traces.  S = serine, E = glutamate. 
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Figure 4.9.  Electropherograms of one sample run by three different methods with GABA 
(γ) peak highlighted out.  The CE-LIF chiral separation method (a) presents a significant 
GABA peak while both two non-chiral methods (b,c) detect only a trace level, suggesting 
a co-eluting peak with GABA in CE-LIF chiral separation method.    
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Table 4.1.  A table summarizing representative quantitation results.  D-Ser quantitation of 
one sample set using three different separation methods on two CE platforms are 
compared.  3 technical replicates were performed with CE-LIF while 1 technical replicate 
was performed with CE-MS.  The final quantitation results of each amino acid were 
calculated from data of all methods, except for GABA.  
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Figure 4.10.  Cortex homogenate, Sb2-containing synaptic vesicles immunoisolated at 
20 °C (leaked GVs) and at 0 °C (intact GVs) were analyzed by CE-LIF.  
Electropherograms are adjusted to the same scale to facilitate the comparison between 
traces.  Arrowheads point to the position of L-Ser (LS), D-Ser (DS), GABA (γ), glycine 
(G) and L-glutamate (E). 
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Chapter 5 
Developing Methods to Measure D-Glutamate, D-
Alanine and D-Proline in Biological Matrix 
Notes and Acknowledgments 
The following members of the Sweedler group assisted in the research presented 
in this chapter.  The assistance of Nobutoshi Ota was vital to achieve the baseline 
separation of D/L-glutamate (D/L-Glu).  Stanislav Rubakhin and Xiying Wang helped 
tremendously with the sample dissection and preparation of rat pituitary and pancreas.  
S.R. also provided numerous insightful suggestions on experimental design. 
5.1 Introduction 
Perhaps the most interesting subset of putative active compounds found within the 
central nervous system (CNS) is the D-amino acids (D-AAs).  Their discovery forced us 
to reconsider the long cherished dogma that only L-amino acids (L-AAs) exist in 
mammalian tissues and body fluids.  The D-AAs found in animal kingdom include D-
serine (D-Ser),[1-6] D-aspartate (D-Asp),[7-12] D-glutamate (D-Glu),[13] D-alanine (D-
Ala),[14, 15] D-proline (D-Pro),[16, 17] D-leucine (D-Leu),[18] D-methionine,[19] D-
Asparagine [20, 21] and D-Arginine.[22]  Among them, D-Ser and D-Asp are studied 
most extensively.  As highlighted in Chapter 4, it is now known that, D-Ser plays critical 
roles in glia-neuron communication through N-methyl-D-aspartate (NMDA) receptor-
mediated signaling processes.[23-27]  Our group also has devoted efforts to demonstrate 
the role of D-Asp in cell to cell signaling using Aplysia californica (A. californica) as a 
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well-characterized neuroscience model system.[11, 12, 28, 29]  Besides D-Ser and D-
Asp, other D-AAs are also found in brain, but their functional roles in nervous system are 
much less studied.  
D-Ala was measured in the brain [14, 30-32] and can function as an co-agonist at 
the glycine binding site of the NMDA receptor, similarly to D-Ser.  D-Ala has been 
reported in both rat pituitary and pancreatic islets using immunostaining.[15]  In 
particular, in the double-immunostaining experiments, D-Ala displayed a similar 
distribution with adrenocorticotropic hormone (ACTH) cells.  When endogenous D-Ala 
was measured in the tissues and physiological fluids of mice with various DAAO 
activities, its amount increased significantly with a lowered D-amino acid oxidase 
(DAAO) activity.[31]  D-Ala was also reported to show circadian changes where its level 
was high during the sleeping period and low during the active period in rats with both 
diurnal and nocturnal habits.[14] 
Since L-glutamate (L-Glu) is the predominant excitatory neurotransmitter in the 
brain, the observation of its D counterpart, D-Glu in the nervous system [33-35] is 
particularly intriguing. D-Glu was also isolated from the liver and kidneys, where D-Glu 
existed at substantial levels, even exceeding that of D-Asp in some cases.[35]  Highly 
sensitive immunostaining also revealed a sparse distribution of D-Glu imunoreactive 
neurons in rat brains.[13]  Moreover, electrophysiological experiments indicated that D-
Glu could induce responses, although less potent compare to L-Glu.[36]  However, 
differed responses to these enantiomers may imply distinct mechanisms of response.  
Earlier work also showed that when rat brain slices were incubated with a medium 
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containing glucose and D-Glu, similar accumulation of L-Glu and D-Glu occurred.  But 
associated accumulation of potassium ion was accelerated less by D-Glu.[37] 
One of the least studied D-AAs, D-Pro was found at relatively high levels in the 
pituitary gland, cerebellum and pineal gland of mice, as well as the pancreas.[16, 17] 
The information obtained so far on D-Glu, D-Ala and D-Pro by various 
measurement techniques is limited.  We hope to develop a suite of approaches to advance 
our knowledge of the presence and activity-dependent release of those putative cell to 
cell signaling molecules.  Depending on the specific questions to be answered, 
measurement can range from entire tissue regions to single cells.  Although so far most 
analytical measurements of these three D-AAs employed high-performance liquid 
chromatography (HPLC), capillary electrophoresis (CE) can be particularly beneficial in 
analyzing small sized samples, such as single cells.  Developing methods on CE platform 
will be our main focus presented here. 
Rat pituitary and pancreatic islets can be good models to study activity-dependent 
release because of their isolated distributed within the tissue.  In addition, since D-Ala 
has been reported to follow a circadian rhythm,[14] suprachiasmatic nucleus (SCN) 
would be an appropriate model to study its relation with biological clock.  For D-Glu, the 
immunostaining of its location in sparse networks can be used as a map to ensure that the 
appropriate neurons are dissected and analyzed.  Single cell assays are highly expected to 
understand the heterogeneity of D-Glu distribution in those sensory neurons which are 
often thought to be homogenous. 
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This chapter describes the ongoing method development on CE platform aiming 
at providing sensitive, reliable measurements of D-Glu, D-Ala and D-Pro.  The newly 
developed analytical methods, in combination with appropriately designed experiments, 
will help to uncover the roles of these D-AAs play in cell to cell signaling in nervous and 
endocrine system.   
5.2 Experimental procedures 
5.2.1 Reagents and solutions 
The D/L-Glu separation buffer solution consists of 80 mM of α-cyclodextrin (α-
CD) in 200 mM of borate buffer (pH 9.5).  An alternative separation buffer for D-Glu 
contains 60 mM α-CD, 20 mM β-CD and 40 mM sodium deoxycholate (SDC) in 100 
mM Borate buffer (pH 9.3).  Naphathalene-2, 3-dicarboxaldehyde (NDA) was from 
Molecular Probes (Eugene, OR, USA).  NDA solution is made in methonal while KCN 
solution is made in 50 mM borate buffer at pH = 9.5.  NDA and KCN solutions are 
mixed with standards or biological samples and the reaction mixture is allowed to react 
for 20 min in dark.  The D/L-Ala and D/L-Pro chiral separation was achieved using the 
following conditions: 20 mM β-CD, 30 mM SDS in 100 mM borate buffer at pH = 10.  
An alternative separation consists of 10 mM γ-CD, 30 mM SDS in 100 mM borate buffer 
at pH = 9.5.  Fluorescein isothiocyanate (FITC) solution is made in acetone.  1 µL sample 
or standard is mixed with 1 µL 1 mM FITC and 8 µL sample buffer (20 mM borate 
buffer at pH = 10.0).  The derivatization reaction is allowed in dark overnight.  Other 
reagents were obtained from Sigma–Aldrich at the highest purity available.  Solutions 
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were filtered through 0.45 m Acrodisc syringe filters (Gelman Laboratory, Ann Arbor, 
MI, USA) before use.   
5.2.2 Capillary electrophoresis instrument 
The system is a previously described, laboratory-built CE-LIF system  [38], 
converted to a 457.9-nm excitation wavelength by adapting the Argon Krypton mixed 
laser (Coherent, Santa Clara, CA, USA), focusing lens and optics.  Analytes are separated 
in an 86 cm long, 50 µm ID/360 µm OD fused-silica capillary, with an effective length of 
50 cm. The separation voltage is set at 20 kV.  The chiral separation is performed under 
conditions with different buffer components as described in 5.2.1. 
5.2.3 Cerebral ganglia and pituitary isolation 
A. californica (200–300 g) were obtained from Charles Hollahan (Santa Barbara, 
CA, USA) and kept in an aquarium containing continuously circulating, aerated and 
filtered sea water (Instant Ocean, Aquarium Systems Inc., Mentor, OH, USA) at 14–15°C 
until used.  Animals were anesthetized by injection of isotonic MgCl2 (~30 to ~50% of 
body weight) into the body cavity.  The cerebral ganglia were dissected and placed in 
artificial sea water (ASW) containing (in mM): 460 NaCl, 10 KCl, 10 CaCl2, 22 MgCl2, 6 
MgSO4, and 10 HEPES (pH 7.8), or in ASW-antibiotic solution: ASW supplemented 
with 100 units/mL penicillin G, 100 g/mL streptomycin, and 100 g/mL gentamicin 
(pH 7.8).  
The rats were anesthetized with diethyl ether and euthanized by decapitation.  
Anterior pituitary, posterior pituitary were quickly excised and stored at -80 °C before 
 129 
 
use. These tissues were homogenized for 2 min in 200× vol of MeOH. The homogenates 
were centrifuged at 4500×g for 5 min to obtain the supernatants.  Filtration was 
performed through microcon
®
 filter (3000 MW) to remove proteins as well as other large 
molecules and the resulting filtrate was evaporated to dryness.  To the residue, 
appropriate amount of buffer was added and the solution underwent CE analysis for the 
determination of the D- and L-amino acids. 
5.2.4 Solvent extraction procedure  
The 40 µL aliquots were dried in the oven overnight and reconstituted with 5 µL 
water or 5 µL internal standards containing 1 µM aminoadipic acid.  The addition of 
internal standard (IS) allowed accurate determination of extracellular D-Glu levels and 
reduces methodological uncertainties.  KCN and NDA solutions were added to the 
reconstituted samples and the reactions were allowed to continue for 20 min in the dark 
to form N-substituted 1-cyanobenz[f]isoindole amino acid (CBI-AA).  The large amount 
of inorganic salts in these samples created issues with CE when the solutions were 
concentrated; thus, the salts were removed via extraction.   Specifically, HCl solution was 
added to the reaction mixture to adjust the pH and the resulting neutrally charged CBI-
AA was extracted into CH2Cl2.  The lower layer was placed into a PCR tube and the 
extraction process was repeated three times.  The combined collected organic layer was 
dried and reconstituted with buffer.  The samples were then assayed via CE as described.   
5.3 Results 
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5.3.1 Method developed to measure D-Glu release from Aplysia cerebral 
ganglia 
5.3.1.1 Liquid-liquid extraction method optimization 
The liquid-liquid extraction procedure was performed similarly as described in 
Chapter 3, section 3.3.2 with the modification of using another molecule as an IS instead 
of D-Glu itself.  Because D-Glu peaks in releasate samples were often small even after 
sample concentration, adding D-Glu as IS was not very practical to ensure precise 
quantitation.   
Several candidates, including β-glutamic acid, threo-β-methylaspartic acid and L-
2-aminoadipic acid, were screened to evaluate their potential of being used as IS (Figure 
5.1).  They have to meet several criteria: 1) having similar structural features and pKa 
profile as Glu; 2) not co-migrating with D/L-Glu peak; 3) not interfering with peaks in 
biological samples.  Among all the candidates, only L-2-aminoadipic acid fulfilled all 
requirements.  It was used in all sample preparation procedure of measuring D-Glu 
release.  
5.3.1.2 Liquid-liquid extraction method validation 
The liquid-liquid extraction method validation was performed similarly as 
described in chapter 3, section 3.3.2, except that the ratio of L-2-aminoadipic acid to D-
Glu was used instead of the ratio of D-Glu to D-Glu+L-Glu (Figure 5.2). 
5.3.1.3 Secretion of D-Glu from whole ganglia 
D/L-Glu enantiomers could be almost baseline separated under the current 
condition.  In Figure 5.3, a clear increase of D-Glu peak could be observed after the 
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whole ganglia was stimulated by an elevated extracellular potassium concentration.  This 
indicated the feasibility of this method in measuring the low abundant D-Glu released 
from A. californica ganglia.  However, among the releasate samples collected (N>5), the 
increase of D-Glu peak was only found once.  This can be attributed to the low 
concentration of D-Glu in the ganglia being tested.  To overcome this challenge, future 
efforts need to be made on locating the regions or particular cell populations which 
contain higher levels of D-Glu. 
5.3.2 Method developed to measure D-Ala and D-Pro in biological 
samples 
5.3.2.1 Optimization of separation conditions 
Compared to other chiral amino acid enantiomers, D/L-Ala are especially 
challenging to separate, perhaps due to its smallest size.  When attached with a relatively 
large fluorescent reagent, this small chirality difference is further reduced, resulting in 
minor differences between derivatized D/L-Ala.  Separation of NDA derivatized D/L-Ala 
was tried with all separation conditions available in our lab, which employed a variety of 
chiral selectors such as α-CD, β-CD, γ-CD, S-β-CD.  However, under those conditions, 
CBI-Ala enantiomers were not separated at all, even without a split at top of the peak of 
their mixtures.  In addition to D-Ala, another D-AA of interest, D-Pro is not a primary 
amine, so it cannot be derivatized with NDA. 
Alternative derivatizing reagents with the ability to derivatize secondary amines 
were tested, including 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F) and fluorescein 
isothiocyanate (FITC).  Surprisingly, standards of both pairs could be easily baseline 
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separated on a number of conditions when FITC was used in derivatization.  This may be 
attributed to the relative size of CD’s cavity and the derivatized analytes.  For example, γ-
CD possesses a truncated cone structure, with a roughly 8 Ǻ inner diameter at the bigger 
end.  Since the naphthalene end of CBI-AA is much smaller than the size of CD cavity, 
CBI-AA is easier to fit that end into the cavity instead of the end with chiral moiety.  As a 
result, the structural difference of chiral moieties contributes less to the difference of 
enantiomers partitioning into the chiral selectors.  The same situation applies to NBD-
AAs.  In contrast, FITC has a much larger 3D structure, arranged perpendicular to the 
functional group that can react with AAs.  With the width of three rings to be more than 
10 Ǻ, the FITC derivatized molecules are more likely to interact with the CD cavity from 
the AA end (Figure 5.4).  If this is the case, small chirality differences interact more with 
CD and as a result, improved chiral resolution may be obtained.  
Baseline separation was achieved for both Pro and Ala enantiomer standards in 
one single run (Figure 5.5c).  This method was then validated by measuring D-Ala in 
anterior pituitary, which was reported to contain D-Ala.[14]  Although D/L-Ala were 
well separated with each other and matched their migration times (Figure 5.5a and 5.5b), 
the putative D-Ala peak showed no difference before and after DAAO treatment (data not 
shown).  DAAO can specific convert the amino group on D-AAs to a keto group.  As a 
result, if nothing co-migrates with the D-AA peak, it should be removed after reaction.  
The almost unnoticeable change of the putative D-Ala peak suggests: 1) comigration of 
unknown molecules with D-Ala occurred under the current separation condition; 2) D-
Ala, if present, was at negligible level in the tested samples.  Previous results also show 
only a few percent of D-Ala in the total Ala pool.  To overcome this challenge of co-
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migration, efforts need to be made on further optimizing the separation condition, 
especially using biological samples instead of pure standards in the optimization process.  
DAAO enzyme reaction provides a good way of distinguishing the authentic D-Ala from 
other compounds co-migrating with it. 
5.4 Conclusions 
In this chapter, methods to quantitatively measure D-Glu release from A. 
californica ganglia was established and validated in biological samples.  Among all 
releasate samples being analyzed, only one showed a low level of D-Glu released after 
simulation event.  Future work can be directed to locate the regions or particular cell 
populations which contain higher levels of D-Glu to facilitate the measurements. 
In addition, efforts have been made to optimize separation conditions for both D-
Pro and D-Ala and examine the reliability of those methods in analyzing biological 
samples.  Both pairs of Pro and Ala enantiomers could be very well separated as 
standards using FITC as a derivatizing reagent.  But when applied in biological matrix, 
this method suffered from poor selectivity, which might be overcome by further fine 
tuning each buffer component. 
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5.6 Tables and figures 
 
Figure 5.1  Results of testing three candidates to be used as IS in measuring of D-Glu 
after a solvent extraction procedure.  L-2-aminoadipic acid was well separated from both 
D- and L-Glu as well as other peaks in biological samples, thus was finally chosen as IS. 
 
  
 141 
 
 
Figure 5.2  Method validation of using L-2-aminoadipic acid as IS in quantifying D-Glu 
after a solvent extraction procedure.  The ratio of peak area of L-2-aminoadipic acid to 
that of D-Glu was plotted against the ratio of their concentration in original samples.  
This equation generated by linear regression curve was used for quantitation purpose. 
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Figure 5.3  An increase of D-Glu peak was shown after chemical stimulation by elevated 
potassium concentration. 
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Figure 5.4  Relative size of CD cavity and FITC. 
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Figure 5.5  Representative electropherograms of pituitary samples (A and B) as well as 
standards (C).  LP = L-Pro, DP = D-Pro, LA = L-Ala, DA = D-Ala
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Appendix A 
Abbreviations 
2D-HPLC Two dimensional-high performance liquid 
chromatography 
A. californica   Aplysia californica 
A. limacine   Aplysia limacine 
AAs    amino acids 
aCSF artificial cerebrospinal fluid 
ACTH    adrenocorticotropic hormone 
AD    Alzheimer’s disease 
AMPA (S)-α-amino-3-hydroxy-5-methyl-4-   
isoxazolepropionic acid 
APOC    (+/-)-1-(9-anthryl)-2-propyl chloroformate 
Asp    aspartate 
BAPTA-AM 1,2-bis(2-aminophenoxy)ethane-N,N,N’,N’-
tetraacetateacetoxymethyl ester 
BGE    backgournd electrolyte 
BOC-L-cys   N-tert-butyloxy-carbonyl-L-cysteine 
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CDs    cyclodextrins 
CE    capillary electrophoresis 
CEC    capillary electrochromatography 
CE-LIF capillary electrophoresis with laser-induced 
fluorescence 
CNS    central nervous system 
CSF    cerebrospinal fluid 
CSP    chiral stationary phase 
CZE    capillary zone electrophoresis 
DAAO-linked   D-amino acid oxidase-linked 
D-AAs    D-amino acids 
D-Ala    D-alanine 
D-Asp    D-aspartate 
D-ASPO   D-aspartic acid oxidase 
D-Leu    D-leucine 
DR    D-Asp racemase 
D-Ser    D-serine 
ECFS    extracellular calcium-free solution 
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eGFP-Cb   eGFP-cellubrevin/VAMP3 
eGFP-Sb2   eGFP-synaptobrevin/VAMP2 
EKC    electrokinetic chromatography 
EOF    electroosmotic flow 
FITC    Fluorescein isothiocyanate 
GC    gas chromatography 
Gly    glycine 
HPLC    high performance liquid chromatography 
HPLC-MS/MS high performance liquid chromatography-tandem 
mass spectrometry 
HP-β-CD   hydroxypropyl-β-cyclodextrin 
HP-γ-CD   hydroxypropyl-γ-cyclodextrin 
L-AAs    L-amino acids 
LC    liquid chromatography 
LC/ESI/MS/MS liquid chromatography-electrospray ionization-
tandem mass spectrometry 
LDCL    luminol-derived chemiluminescence 
LED    light-emitting diode 
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LEDIF    light-emitting diode induced fluorescence 
LIF    laser-induced fluorescence 
LOD    limit of detection 
MCE    Microchip electrophoresis 
MD-CE   microdialysis-capillary electrophoresis 
MS    mass spectrometry 
NAC    N-acetyl-L-cysteine 
NBD-F   4- fluoro-7-nitro-2,1,3- benzoxadiazole 
NDA    naphthalene-2,3-dicarboxaldehyde 
NMDA   N-methyl-D-aspartate 
OPA    o-phthalaldehyde 
PBS    phosphate-buffer saline 
PD    Parkinson’s disease 
PFPA    pentafluoropropionic anhydride 
PKC    protein kinase C 
pkDAAO   porcine kidney D-amino acid oxidase 
PPD    poly-m-phenylenediamine 
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PVN    paraventricular nuclei 
RgDAAO   Rhodotorula gracilis D-amino acid oxidase 
SDC    sodium deoxycholate 
SDS    dodecyl sulfate 
SIM    selective ion monitoring 
SNAREs   soluble NSF attachment protein receptors 
SON    supraoptic nuclei 
SR    serine racemase 
SRM    selective reaction monitoring 
S-β-CD   sulfated β-cyclodextrin 
UV    ultraviolet 
VN    vestibular nuclei 
β-CD-MEKC β-cyclodextrin-micellar electrokinetic 
chromatography 
 
 
 
 
